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Abstract 
 
Keywords: high performance liquid chromatography, micellar electrokinetic chromatography, 
capillary electrophoresis, ibuprofen, metabolites, validation, wastewater, aerobic granule  
 Pharmaceuticals have become priority emerging environmental pollutants. 
Environmental monitoring and toxicological studies are essential to establish maximum 
permissible limits in the environment. Furthermore, innovative wastewater treatment is 
required for their degradation. Águas do Algarve is constructing an aerobic granule plant to 
modernize wastewater treatment for the cities of Faro and Olhão. The company is interested in 
research regarding granule ability to degrade pharmaceuticals detected in wastewater influent.  
 Two aerobic granule sequencing batch reactors were constructed and operated at 
laboratory scale using different cycles (anaerobic/aerobic and aerobic). The efficiency of the 
reactors and type of operating conditions was investigated for the degradation and removal of 
ibuprofen and its metabolites 2-hydroxyibuprofen, 1-hydroxyibuprofen and carboxyibuprofen.  
Two methods, high performance liquid chromatography (HPLC) and micellar 
electrokinetic chromatography (MEKC), a form of capillary electrophoresis, coupled with 
UV/Vis, were developed to detect and quantify ibuprofen and its metabolites. Solid phase 
extraction was used to preconcentrate the compounds to method detection limits, however 
recoveries were problematic. Eluents were dried and reconstituted in solvent (milli-q water) 
for compatibility to both methods. Separation conditions for the compounds were optimized. 
Both methods were validated in solvent (milli-q water) for linearity, recovery, LOD, LOQ, 
precision (repeatability and intermediate precision), range and selectivity. Selectivity could be 
obtained for both methods. However, acceptable linearity, LOD, LOQ, repeatability and 
recovery could not be established in the desired working range. Additionally, robustness 
problems particularly for the MEKC method may have affected validation results. For some 
compounds, both methods failed to meet statistical tests applied for acceptance of linearity and 
repeatability. Solvent and synthetic wastewater calibration were compared using student’s t-
test. There was no statistically significant difference between the curves for the HPLC method 
in contrast to those of the MEKC method.  
The methods were applied to synthetic wastewater samples taken from the SBRs. Each 
method detected different analytes with 1-hydroxyibuprofen observed in HPLC and 
carboxyibuprofen observed in MEKC. The calculated concentrations exceeded method range. 
Revalidation of both methods and reanalysis of the samples is required to verify accuracy of 
results and confirm suitability for intended application. 
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Objective of Study 
 
The first objective of the study was to develop, optimize and validate new analytical 
methods for the detection and quantification of ibuprofen and the three metabolites, 1-
hydroxyibuprofen, 2-hydroxyibuprofen and carboxyibuprofen in synthetic wastewater. The 
compounds were chosen due to frequent detection in wastewater treatment plants (WWTP) 
influent and effluent, surface (rivers/lakes/streams), ground and drinking waters. The methods 
developed were high performance liquid chromatography (HPLC) initiated at the 
Universidade do Algarve (UAlg) and completed at the University of São Paulo and capillary 
electrophoresis (CE) at the University of São Paulo (USP). Both methods were used to detect 
and quantify the compounds in synthetic wastewater samples taken from two aerobic granular 
sequencing batch reactors (SBRs). Separation conditions for both methods were optimized for 
resolution of compound peaks and analytical time, then validated for the application. Solid 
phase extraction was performed to pre-concentrate the analytes, facilitating analysis at the 
trace concentration range commonly detected in the environment and for the dosage applied to 
the reactors. The performance of both methods would be compared statistically using student’s 
t test for the results of sample analysis. Solvent and synthetic wastewater calibration curves 
would also be compared using student’s t-test to assess matrix effect on validation parameters. 
The second objective of the study was the construction and operation of two aerobic 
granule SBRs at laboratory scale. Both SBRs were operated using different cycles, 
anaerobic/aerobic and aerobic conditions respectively to compare the efficiency of this 
wastewater treatment and the type of operating cycle on the degradation and removal of 
ibuprofen and the metabolites. Samples for analysis were taken at selected timepoints during 
one cycle for analysis by the HPLC and CE methods. 
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1. Introduction and Literature Review 
 
1.1 Pharmaceuticals: Emerging Pollutants in Water 
 
 Pharmaceuticals are indispensable to the preservation of global public health1. 
Consumption has increased concurrent to prolonged human life expectancy, shifting 
population demographics, rising global population, rapid urbanization, research 
advancement and enhanced market availability and affordability1–3. Consequently, 
pharmaceuticals, their metabolic and transformation products are increasingly detected 
in trace concentrations (ng to µg/L) in the aquatic (surface, ground and drinking 
waters) and terrestrial (soil and manure) environment and wastewater treatment plants, 
garnering great concern as emerging environmental pollutants2–7.  
 Extensive environment studies have been published, with emphasis on the 
predominantly used therapeutic classes such as nonsteroidal anti-inflammatory drugs 
(NSAIDs). Current knowledge is limited on the definitive effects of all detected 
pharmaceuticals. Nevertheless, research has given evidence to the potential damage 
resulting from the bioaccumulative effects of chronic exposure and continuous 
introduction into the environment2,3,7–9. Their potentially dangerous environmental 
impact arises from their inherent ability for unhindered biological activity at sub-
therapeutic concentrations2,8,10,11. 
Apprehension is greatest for aquatic pollution due to the inescapable life-cycle 
exposure of these organisms and possible disruption of the food chain at the primary 
producer level6,8. Metabolic or transformation products may exhibit similar or higher 
toxicity than parent compounds12,13. A database compiled by the United Nation’s 
Strategic Approach to International Chemicals Management revealed the detection and 
quantification of 671 pharmaceuticals inclusive of their metabolic and transformation 
products in 71 countries. The data, while collected mainly from Western Europe, 
United States and Canada, indicate that this is a global problem2. 
Pharmaceuticals are introduced to the aquatic and terrestrial environment 
through anthropological activities including industrial production, animal husbandry, 
household and clinical use and effluent from wastewater treatment plants (WWTPs) 
(Figure 1) 2,3,7,14. WWTPs are the dominant emission pathway, particularly for the 
aquatic environment. Human and animal excreta (faeces and urine), remnants of 
industrial production and discarded clinical and domestic pharmaceutical waste are 
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transported via the sewage 
system to WWTPs and 
released via wastewater 
effluent into the 
environment2,7,10,15,16. The 
pharmaceuticals detected and 
their concentration are 
contingent upon location of the 
WWTP, season and 
geographical region2,3. This 
problem arises from the 
operational intent of WWTPs, 
which are designed for the 
treatment of biological waste 
to reduce carbon, nitrogen and 
phosphorus loads. 
Additionally, WWTPs employ 
a high degree of dilution 
during treatment and release, 
hindering the contact time9. 
Many pharmaceuticals, their 
metabolites and transformation 
products are resistant to the treatment, hence their persistence in WWTP effluent2,17.  
1.2 Compounds of Study: Ibuprofen and Metabolites 
 
 This thesis focuses on ibuprofen (IBU), one of the most popular NSAIDs 
available on the market, and its metabolites - 1hydroxyibuprofen (1OH), 2-
hydroxyibuprofen (2OH) and carboxyibuprofen (CBX). Ibuprofen, discovered in 
195018, is designated as an essential medicine by the World Health Organization. The 
pharmaceutical is easily available via prescription and over the counter and used in 
pain, inflammation and other chronic arthritic treatment19,20. Brazil is a substantial 
consumer of pharmaceuticals concomitant to its large population but accurate, reliable 
data on volume and therapeutic classes used, is difficult to obtain21. For Portugal, the 
latest INFRAMED data shows that 2011 sales of over two million packages 22.  
Disposed 
waste 
Figure 1. Pharmaceutical emission pathways into the aquatic and 
terrestrial environment 
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Pain and/or fever due to 
infection and/or injury stimulate 
the cyclooxygenase (COX) 
pathway where COX-1, COX-2 are 
involved in prostaglandin 
synthesis. This activates the 
vertebrate and invertebrate 
inflammatory response to initiate 
curative measures. Ibuprofen acts 
as a non-selective inhibitor through 
reversible binding to both COX 
isozymes, reducing their activity 
and consequently prostaglandin 
synthesis and inflammation (Figure 
2). These enzymes also play critical roles in prostaglandin synthesis in the 
reproductive, gastro-intestinal, blood and nervous systems 23–25.   
Human metabolism produces 1-hydroxyibuprofen, 2-hydroxyibuprofen and 
carboxyibuprofen 20,26. Their structure and conversion from the parent compound are 
shown in Figure 327. These products are observed in environmental studies of 
ibuprofen biodegradation in wastewater, except that CBX is produced first and 
generally has the higher concentration 27–32. The pharmaceutical is almost completely 
metabolized, with 15% of ingested IBU excreted in urine, 25-26% as 1OH and 2OH 
and 37-46% as CBX20,33. The compounds are weak hydrophobic acids, possessing 
carboxyl (COOH) and aromatic benzene ring functional groups. Their chemical names 
and physicochemical properties are given in Table 127.  
Table 1. Structure and physico-chemical properties of compounds of interest 
Compound Chemical Name Molecular Weight 
g/mol 
pKa Log 
Kow 
Ibuprofen 2-(4-Isobutylphenyl)propanoic 
acid 
206.281 4.91 3.97 
1-
hydroxyibuprofen 
2-[4-(1-Hydroxy-2-
methylpropyl)phenyl]propionic 
acid 
222.284 4.55 2.69 
2-
hydroxyibuprofen 
2-[4-(2-Hydroxy-2-
methylpropyl)phenyl]propionic 
acid 
222.284 4.63 2.37 
Carboxyibuprofen 3-[4-(1-carboxyethyl)phenyl]-
2-methylpropanoic acid 
236.267 3.97 2.78 
Figure 2. Ibuprofen mode of action on the COX pathway 
Arachidonic 
acid release
COX-1/COX-2 
Activation
Inflammatory  
response
Prostaglandin  
synthesis 
 
Pain/ Fever/ 
Infection/Injury 
Ibuprofen  
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1.3 Water Quality Legislation and Monitoring  
 
The United Nations highlights the 
fundamental importance of ecological 
conservation and sustainability of good, 
safe and adequate water and treatment of 
urban wastewater for public health and 
socioeconomic development34. Countries 
have enacted regional and/or national 
legislation to meet this global priority. 
Brazil legislates water quality and 
conservation by the National Water 
Resource Policy and National Water Resource Management System, reinforced by 
additional state regulations (Figure 4)35.  The European Union (EU) uses the Water 
Framework Directive 2000/60/EC to establish policies and measures for water quality, 
safety, resource conservation and pollution reduction. Supplementary directives36–38 
are enacted for prioritization and environmental monitoring of selected compounds 39–
42, environmental quality standards42, wastewater collection, treatment and discharge 
regulation 43,44 and sewage sludge use in agriculture45 (Figure 5).  Recognizing 
pharmaceuticals as emerging environmental pollutants, Directive 2013/39/EU, updates 
the Water Framework Directive to initiate their inclusion to the watch list of 
environment priority compounds for monitoring and specific action. The aquatic 
environment is the predominant matrix of concern. The list is subject to revision 
arising from research identifying other pharmaceuticals as environment risks. 
Brazil 
National Law 
Water Law, 1997, Law No. 9.433 
establishing National Water Resource 
Policy and Resource Management 
System 
State Law 
E.g. State of São Paulo, Decree No. 32.955, 
1991 
Figure 4. Water quality and safety legislation in Brazil 
2-hydroxyibuprofen  
Carboxyibuprofen  
1-hydroxyibuprofen  
Ibuprofen  
Figure 3. Chemical structure of IBU, 1OH, 2OH and CBX  
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Individual member states such as Portugal, enact EU directives through national-
specific legislation (Figure 5)35,46.  
 
It is recommended that environmental regulatory agencies focus monitoring 
programs by selecting priority pharmaceuticals based on country specific consumption 
and environment risk assessments. This allows the calculation and evaluation of 
pharmaceutical environmental liability by predicted or measured environmental 
concentration and toxicity data to three different trophic levels of the aquatic 
ecosystem (algae, daphnids and fish).  However, the certainty of minimal environmental 
impact from pharmaceuticals deemed to have no or low risk (≤1), has been questioned 
for several reasons. Risk assessments are conducted on individual pharmaceuticals, 
excluding their realistic occurrence in the environment as mixtures with the same or 
different therapeutic classes and other compounds. Some studies proved significant 
additive effect and higher toxicities of pharmaceutical mixtures from same or different 
therapeutic class on algae47–53. Additionally, the ecotoxicological impact of chronic 
exposure over the lifespan of aquatic organisms and the toxicity of pharmaceutical 
metabolites are rarely studied 54–56. These considerations along with the inherent 
pharmaceutical ability for biological activity at sub-therapeutic concentrations, have 
prevented the establishment of maximum permissible limits for ibuprofen and other 
Figure 5. Water quality and safety legislation in the EU and Portugal 
Water resource protection 
and conservation
Water Framework Directive 
2000/60/EC 
Environmental Priority 
Compound Watch List
Decision 2455/2001/EC
Directive 2013/39/EU
Environment Quality 
Standards
Directive 2008/105/EC 
Drinking Water
Directive 98/93/EC
Bathing Water
Directive 2006/7/EC 
Wastewater regulation
Directive 91/271/EEC
Directive 98/15/EC
Directive 86/278/EEC 
Shellfish Waters
Directive 2006/113/EC 
EU Portugal 
Water pollution 
Decree-Laws No. 
58/2005 and 
208/2008  
Monitoring of 
environmental 
priority compounds 
Decree-Laws No.  
83/2011 and 
103/2010  
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pharmaceuticals in surface and ground waters and treated wastewater effluent. 
Monitoring data and assessments of chronic ecotoxicological effects are required to 
define these limits and select pharmaceuticals for monitoring programmes22,54,57,58. 
1.4 Environmental Detection and Risk Assessment of Ibuprofen and Metabolites  
  
The EU is 
considering the 
addition of ibuprofen to 
the watch list of 
priority 
pharmaceuticals of 
environmental concern, 
due to the frequent 
detection in the aquatic 
environment and 
potential impact 59–61. 
Its medical popularity means it has been extensively studied to evaluate its presence 
and potential risk in the environment. In literature review for this thesis, wastewater 
influent and effluent was the most studied environmental matrix and had the highest 
rate of ibuprofen occurrence as shown in Figure 6 17,22,32,54,57,62–101. In the United 
Nation Strategic Approach to International Chemicals Management database, 
ibuprofen is ranked as the third most detected pharmaceutical in surface, drinking 
and ground waters and is detected in 47 countries2. The concentrations measured and 
aquatic matrix studied are given in Table 2. Few studies include the metabolites, 
which were typically found in greater concentration than the parent compound, 
particularly in WWTP effluent. This indicates degradation and metabolite formation 
before entry into WWTPs and during the treatment process32,87,102. In the last few 
years, researchers have recommended extending environmental studies to include 
metabolites12,55,103,104. Higher concentrations are measured in colder countries, colder 
seasons and WWTPs close to densely populated areas57,101. In Brazil, studies of 
several Rio de Janiero WWTPs measured average ibuprofen concentration ranges in 
influent of 1-27 µg/L and effluent of 4.7- 40 µg/L, consistent to a large population80. 
In Portugal, measured mean influent concentrations were 3, 3.9, 5.3, 9.80 µg/L in 
spring, summer, autumn and winter respectively with lower effluent concentrations 
4. 2%
33. 19%
10. 6%
58. 33%
58. 33%
6. 4%
2. 1% 4. 2% Ground water
Surface waters
(rivers/lakes/streams)
Seawater
WWTP Influent
WWTP Effluent
Sludge
Soil
Drinking Water
Figure 6. Distribution detection of Ibuprofen and environmental matrix of study 
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of 0.16, 0.3, 1.5, 1.8 µg/L in spring, summer, autumn and winter respectively 22,57. 
The highest concentrations are observed in the Algarve, Alentejo and Center regions 
in the winter influenced by population size and colder temperatures, where individual 
WWTPs concentrations could be as high as 30 µg/L. 
Table 2. Measured ibuprofen and metabolite concentration ranges and aquatic matrix of study 
Aquatic Matrix Ibuprofen 
Concentration Range 
µg/L 
Metabolite Concentration Range 
µg/L 
Hydroxyibuprofen Carboxyibuprofen 
WWTP influent 4-228 1.9-2.0 41-120 
WWTP effluent 0.01-4 2.8-3.6 n.d 
Seawater n.d.-40 0.2 1.2 
Surface water 
(rivers/lakes/streams) 
0.008-2   
Drinking water 0.04-0.05   
Groundwater 0.02-0.05   
                  n.d-below limit of detection 
 
Numerous studies have been conducted to assess the environment toxicity and 
risk of ibuprofen with differing results. Some have classified ibuprofen as low risk in 
surface and wastewaters22,57,105. In contrast, several authors mark ibuprofen as a 
significant environmental risk21,55,77,86,106–108. No risk assessments have been performed 
for the metabolites. It is believed they have no pharmacological activity109,110, however 
one study has shown the toxicity of 1OH and 2OH to luminescent bacteria111. 
Toxicity studies have proven that ibuprofen is an aquatic environmental hazard, 
as a single compound or magnified with other pharmaceuticals49,107. Through its 
therapeutic action as a COX inhibitor, it causes toxic inhibition of growth, reproductive 
and inflammatory response of organisms at the trace concentrations commonly 
measured in the aquatic environment. These include primary producers - algae50,112–117, 
phytoplankton50,112, rotifers118 and zooplankton50 and common food sources such as 
fish119–123, mussels124–130, clams131 and oysters132. It also promotes the proliferation of 
cyanobacteria in competition with algae112. The targeting of primary producers and 
food sources has potential disruption to the food chain and entire ecosystem.  
1.5 Wastewater Treatment of Ibuprofen and Metabolites  
 
Conventional biological and/or chemical methods are used to treat WWTP 
influent for the production of effluent that meets quality and safety standards43,44,133,134. 
Pharmaceutical removal from WWTPs is reliant upon its physicochemical properties, 
the treatment method, operational conditions and season135–137. Research has 
demonstrated the success of several methods in the removal of some pharmaceuticals 
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including aerobic and anaerobic biodegradation, sorption to WWTP sludge and 
oxidation 9,134,138. Biological treatment is greatly favoured for its high efficiency, low 
cost and utilization of the metabolism of naturally occurring microbial communities to 
remove or transform compounds to nontoxic products139.  
Ibuprofen has a high removal percentage in WWTPs ranging from 80-100% 
from influent to treated effluent, dependent on season and treatment 
employed22,57,65,69,78,83,84,93,135,140,141. The metabolites exhibit similar removal, but it is 
uncertain whether this is mineralization or transformation to other compounds 27,142. 
Aerobic biodegradation has been confirmed as the key removal method of these 
compounds in WWTPs9,30,143–146. Studies have isolated the responsible bacterial 
strains147–152. Their chemical structure allows easy degradation by hydrolysis of the 
carboxylic acid group and carbon atoms on the aromatic ring (cleaving the ring). 
Removal by sludge sorption is minor, due to their hydrophobicity and negative 
electrostatic charge derived from their Log Kow and pKas (Table 1) 
9,143,144,153,154.  
Despite its high removal in WWTP, ibuprofen is considered an emerging 
pharmaceutical pollutant. Widespread usage results in the presence of ibuprofen and 
the metabolites in WWTP effluent, surface, ground and drinking waters9,22,54,93. 
Additionally, ibuprofen appears to be merely transformed into compounds of similar 
complexity and properties instead of being completely degraded. Most studies of its 
removal, identify and quantify the parent compound only, excluding the metabolites. 
Furthermore, ibuprofen exists in two isomeric forms and the bacteria responsible for its 
biodegradation preferentially utilize the pharmacologically inactive isomer, resulting in 
higher concentration and slower degradation of the pharmacologically active 
isomer28,32,88. These dual factors increase the likelihood of environment impact at trace 
concentrations of ibuprofen and its metabolites and highlight the need for innovation 
on wastewater treatment methods despite the high removal in conventional WWTPs. 
1.6 Aerobic Granular Sludge  
 
The aerobic granular sludge system is an innovative advancement in biological 
wastewater treatment155,156. It has several advantageous characteristics in comparison 
to conventional WWTPs, including high biomass retention, faster settling properties, 
capability of simultaneous COD, nitrogen and phosphate removal, good biosorption 
properties and high resilience to chemical toxicity and toxic shock load. Its simplicity 
and flexibility facilitates adaptability of operational cycles and conditions to 
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characteristics of wastewater influent, weather conditions, actual sludge conversion 
rates and desired effluent conditions with added benefits of lower operational costs and 
required operational land space157–161. 
Extensive research has been conducted in lab scale to optimize the operational 
parameters including understanding the 
mechanisms and bacterial processes162–167; 
influential factors for granule formation 
and maintenance such as optimal diameter, 
influent composition and start-up 
inocolum162,164,168–173; reactor design, 
dimensions, operational 
conditions156,166,174–182 and the compounds 
that can be degraded by the granules158,159,167,183–185. The granules form by self-
aggregation of microbial communities and have a stratified structure of aerobic and 
anaerobic layers (Figure 7). During aeration, polyphosphate and glycogen accumulating 
organisms employ growth metabolic processes using oxygen in the outer layer. 
Simultaneously, nitrite oxidation by nitrite oxidizing bacteria in the aerobic zone and 
nitrite reduction by denitrifiers in the anaerobic zone occur respectively. Hence the 
granule capability for concurrent removal of COD, phosphorus and nitrogen 162–
168,179,186. Their stability and efficiency is directly dependent on their size (optimum 
diameter of 2-4 mm), to which dissolved oxygen saturation levels are critical. Studies 
have shown the granules are highly resilient to toxic compounds. Their significant 
potential for application to pharmaceuticals and other toxic compounds lies in the 
adaptability of their biodegradation properties through tailoring of carbon source, 
influent composition and operational cycle158,159,167,183–185,187,188.The system is operated 
in sequencing batch reactors (SBRs) with a four-phase operational cycle as illustrated in 
Figure 8. Early studies of aerobic granule systems employed mainly aerobic cycles156. 
Subsequent optimization studies for granule stability, efficiency and effluent production 
conforming to EU standards, have determined that the anaerobic/aerobic cycle is best 
suited. Operational differences lie in the longer length of influent feeding and shorter 
aeration period in the anaerobic/aerobic cycle versus the aerobic cycle. SBRs can be 
started using activated sludge or already formed granules as inoculum. Several 
parameters can be monitored and/or measured to assess SBR efficiency and granules 
applicable with the desired research objective 156,166,174–182. Some key factors 
Figure 7. Schematic representation of aerobic granule 
stratified structure164 
22 
consistently managed in operation of aerobic granule SBRs at lab-scale and considered 
in SBR construction for this study are described in Table 3. 
 
 
 
 
 
 
 
 
 
 
 
Pilot plants were installed across Europe under the Nereda® company, initiating 
aerobic granules as a full scale urban wastewater treatment166,189–191. In Portugal, Águas 
do Portugal has operated the Lisbon Frielas Nereda plant since 2011 producing effluent 
conforming to EU urban wastewater regulations192. With its success, Águas do Algarve 
commenced the construction of a Nereda® WWTP plant in 2017, to service the cities of 
Faro and Olhão. The project was undertaken to address the current limitations of the 
existing Faro Noroeste and Olhão Nascente WWTP lagoon treatment systems to produce 
effluent that meet EU regulations due to increased capacity. Águas do Algarve aims to 
enact protection, rehabilitation, and sustainability measures to reduce pollution of the Ria 
Formosa Lagoon. The current systems are dual stage treatments, with influent first 
processed in activated sludge reactors, followed by UV treatment before release into the 
Ria Formosa193–197. 
Studies have shown the great potential of aerobic granules in the treatment of 
wastewater containing pharmaceuticals (fluoroquinones, chirals, antibiotics and 
NSAIDs), with degradation occurring after adaptation to the compounds198–203. Zhao et al. 
conducted the sole study on aerobic granule efficiency on ibuprofen degradation. An 
aerobic SBR operated with synthetic wastewater, was dosed with a mixture of ibuprofen, 
naproxen, prednisolone, norfloxacin, and sulfamethoxazole at a concentration of 50 µg/L 
respectively. The results showed a removal of only 34-45% compared with the other 
compounds which had low removal rates in the early stages but increased during the 
Influent feeding (no 
aeration) 
Uptake of carbon source 
by granule microbial 
communities
Aeration
Occurrence of 
nitrification, 
denitrification, COD, 
phosphorus and 
biodegradation
Settling (no 
aeration)
Granules allowed to 
settle to bottom of 
SBR
Effluent 
Withdrawal (no 
aeration) 
Release of treated 
effluent
Figure 8. Operating cycle of aerobic SBRs 
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operational period. The author noted that the result may be due slower rate of aerobic 
biodegradation for ibuprofen. No studies thus far have examined the removal of the 
metabolites formed during wastewater treatment204. Further research is required to 
confirm the capability of aerobic granules to reproduce similar and/or better degradation 
patterns as found in conventional WWTPs. 
 
Table 3. Factors critical to aerobic granule formation and SBR operation 
Condition Recommendation Impact on Granule Formation and 
Reactor Operation 
Ratio of SBR height to 
SBR internal diameter 
Large height to internal diameter 
ratio  
Promote high shear force, 
microorganism proliferation and 
granule formation through selection of 
fast settling particles and washout of 
floccular sludge during settling time 
and effluent withdrawal 
Temperature Room temperature (20-250C) Promotes granule stability as an 
optimum condition for COD, nitrogen 
and phosphorus removal processes 
Aeration Controlled air flow that produces 
small air bubbles introduced at 
bottom of SBR  
Promotes granule mixing with influent 
and aeration for COD, nitrogen and 
phosphorus removal processes 
Dissolved oxygen 
saturation  
≥ 20% 
 
20-50% DO ensure granule stability 
and efficiency, promoting a larger 
anaerobic layer with decreased 
penetration depth of oxygen and 
promote nitrification/denitrification 
processes. 
pH Monitored and controlled as 
necessary 7.0±0.2 
Optimum condition for COD, nitrogen 
and phosphorus removal processes 
Hydraulic retention 
time 
< 8 h Promote microorganism proliferation 
and granule stability by decreasing 
suspended biomass growth by 
washout in effluent withdrawal 
Influent  • Controlled flow introduced at 
bottom of SBR  
• High COD 
Good interaction with granules  
Promote microorganism proliferation, 
granule formation and stability.  
Effluent withdrawal • At least 40% volume exchange 
ratio (percentage difference 
between reactor volume and 
volume refilled after withdrawal) 
• Effluent withdrawal at 
approximately SBR mid height  
Volume exchange ratio > 40% selects 
for granule formation. 
Withdrawal height selects for fast 
settling particles  
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2. Analytical Methodology 
 
2.1 Analytical Methods Employed to Analyse Ibuprofen in the Aquatic Environment 
 
The method of choice for pharmaceutical environment monitoring is high 
performance liquid chromatography (HPLC) coupled to tandem mass spectrometry 
(LC-MS/MS), because of high selectivity via unique mass to charge ratio of ionized 
analytes5,55,60. Literature review reveals numerous analytical methods for ibuprofen 
with other pharmaceuticals. Ultraperformance liquid chromatography dominates the 
field 17,27,30,62,74,87,93,94,97,136,148,150,205–210, followed by LC-MS/MS85,101,204,209,211–216. Gas 
chromatography requires derivatization of the acidic compound, increasing analytical 
time32,55,62,95,96,98–100,217–221. Other detectors used are ultraviolet visible (UV/Vis) diode 
array detectors (DAD)147,222,223, DAD coupled to fluorescent86,153,224–227 and mass 
spectrometer221. Sample pretreatment by an extraction method was always performed 
for all studies to enrich pharmaceutical concentration to method detection and 
quantification limits. Very few methods include the metabolites27,30,87,142.  
Several capillary electrophoresis (CE) methods have been developed for the 
quantification of ibuprofen in pharmaceutical analysis 228–239 and environmental 
analysis in surface water 240,241, tap water 242, wastewater92,243 and bottled water244. The 
quantity pales in comparison to liquid and gas chromatography. Ahrer et al. assessed 
ibuprofen analysis in surface water using HPLC-MS and CE-MS and determined that 
the methods were comparable. However, two extraction procedures were used to boost 
CE method detection limit comparable to HPLC, one was used for HPLC240. CE has 
gained recognition as a viable alternative on par with HPLC, for pharmaceutical and 
clinical analysis with potential application to environmental analysis232,245–249. 
Research potential remains for the development of rapid, simple, accurate and 
precise methods for environmental monitoring of specific pharmaceuticals, that include 
their metabolites5,55. Budget and experience limitations may restrict implementation of 
the complex liquid chromatography methods coupled with mass spectrometry. HPLC 
coupled to UV/Vis detectors can still be a feasible and cost effective analytical method 
with desired sensitivity, accuracy and precision. Environment method development can 
be difficult due to the complex matrices, potential interferences and the low limits of 
detection and quantification required (ng to µg/L).  
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2.2 High Performance Liquid Chromatography (HPLC) 
 
  The foundation for HPLC was laid in the 1900s by Tswett250,251. More than a 
century later, research advancements have transformed HPLC into a universal 
separation technique for numerous compounds of wide-ranging physico-chemical 
properties. Its favoured advantages lie in fast, reliable separation, reproducibility, 
precision and accuracy of results and re-usability of chromatographic columns245,252. 
Figure 9 presents the typical HPLC modular system configuration245. High pressure 
pumps drive mobile phase through 
the column at a selected flow rate. 
Samples are injected manually or 
by autosampler, passing through 
the column where separation 
occurs and analytes generate a 
response in the detector. The 
column is installed inside an oven 
whose temperature can be regulated. The entire system is monitored and controlled by 
a computerized software.  Responses are displayed in chromatograms with peak area 
as a function of retention time. Analyte concentration in samples is calculated by 
comparison of response to that of reference standards245,253. HPLC separates analytes 
by their differing affinity and interactions that creates different distributions to a solid 
column stationary phase and the liquid mobile phase251,254.  
Liquid chromatographic techniques can be sub-divided according to the 
stationary phase of chromatographic column as shown in Figure 10. Various detectors 
exist for sample specific, bulk property measurement and hyphenated techniques 
including UV/Vis, fluorescent, mass spectrometer, tandem mass spectrometer251,254.  
 
2.2.1 Reverse Phase Chromatography 
Reverse phase chromatography works by differing analyte adsorption to the 
stationary phase and is recommended for separating compounds with the same 
functional group251,254. The stationary phases are non-polar and hydrophobic, while 
mobile phases are polar and hydrophilic. The principal chromatographic conditions 
controlling analyte separation are shown in Figure 10 251,254,255. 
Figure 9. Schematic representation of HPLC system245 
Solvent flow path 
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Isocratic or gradient elution modes are employed. Isocratic elution separates 
analytes using constant mobile phase composition, while gradient elution separates by 
increasing the percentage of organic solvent (%B) to continuously change mobile 
phase composition. A linear gradient is the simplest, maintaining constant change in 
%B during the run. The most appropriate gradient shape for analyte separation is 
identified in method development. Researchers recommend an exploratory linear 
gradient run to assess whether isocratic or gradient separation is most suited 255: 
∆tr/tG                        Equation 1 
where ∆tr is the difference in retention times of the final and first peaks. tG is the 
gradient time. Isocratic elution is possible for values ≤ 0.25, while gradient elution is 
recommended for values ≥ 0.40. For intermediate values, the best elution mode is 
determined by experimentation. %B to be used to test isocratic elution is calculated by: 
isocratic %B ≈ 6.3 (travg – tD) - 2       Equation 2 
where travg is the average of the retention times of the first and last peaks and td is the 
hold-up time and is determined by dividing the dwell volume by flow rate.  
Liquid Chromatography
Column
Polarity
Mobile Phase
Temperature
Stationary phases 
Reverse phase (non-polar) 
Normal phase (polar)   
Ion exchange 
Hydrophilic interaction 
Size exclusion 
Ion pair 
Non-aqueous reverse phase 
Dimensions 
Length 
Internal diameter 
Particle size 
 
Analyte 
Mobile phase  
Column stationary phase 
 
Column compartment 
Sample compartment 
Composition: buffer, organic solvent, water 
Separation mode: isocratic elution (constant), 
gradient elution (changing) 
pH: water, buffer 
Percentage of organic solvent 
Elution strength 
Ionic strength: buffer concentration 
Flow rate 
 
Figure 10. Important factors for liquid chromatography separation 
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1. Columns 
Column selectivity is determined by type of stationary phase and analyte 
molecular structure that cause differing interactions such as hydrophobic and dipole-
dipole. The strength of these interactions differs with analyte polarity. Analytes elute 
from least to most hydrophobic (highest to least polarity)245,251,254. Alkyl silica 
particles bonded to ligands such as C18 is the preferred reverse phase stationary 
phase, with pH range 2.5 - 7.5. The silica particle surfaces can also be chemically 
modified.  Column length (typically 10-25 cm) and internal diameter (i.d.) (typically 
2.0-4.6 µm) have a direct proportional effect on retention time. This results in reduced 
analysis time with shorter columns and smaller volumes of mobile phase used as 
internal diameter decreases. Particle size (typically 1.5–5 µm) is indirectly 
proportional to column efficiency, which decreases as particle size increases245,251,252. 
2. Mobile Phase 
Reverse phase mobile phases are composed of water or buffer (solvent A) with 
volatile organic solvents usually methanol, acetonitrile or tetrahydrofuran (solvent B). 
Mobile phase polarity and elution strength are dependent on its composition (water, 
buffer type and concentration, %B, organic solvent and pH). This dictates analyte 
retention time, changing their affinities due to the different polarities of the stationary 
phase and mobile phase. Water is the weakest solvent, followed by methanol and then 
acetonitrile. Acetonitrile commonly applied for short analysis time. pH controls 
selectivity according to analyte pKa. pH can be adjusted to convert analytes to neutral 
or ionic form, changing retention time and elution order245,254,256. Elution strength is 
also controlled by separation mode, remaining constant during isocratic elution, but 
increasing incrementally during gradient elution245,256.  
3. Temperature 
Analyte retention is indirectly proportional to temperature, with retention time 
decreasing with increasing temperature which lowers mobile phase density245,256. 
2.2.2 Chromatographic Quality Parameters 
 
The following parameters are investigated during method development and 
optimization and then evaluated to assess chromatographic quality and separation: 
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1. Retention 
The retention factor of an analyte is the ratio of the quantity of analyte in the 
stationary phase to the quantity in mobile phase and calculated using245,257: 
Isocratic retention factor, k = (tr - t0) /t0                                                                                          Equation 3 
 
where tr is the analyte retention time; t0, column dead time, is the retention time of the 
solvent peak. t0 is obtained from visual inspection of the chromatogram for the first 
baseline disturbance, estimated using flow rate and column dimensions or determined 
by injection of an unretained compound such sodium nitrate. 
 
Gradient retention factor (k*) = (0.87 tGF)/ Vm∆φS                                       Equation 4 
 
Where tG is the gradient time; ∆φ is the change in %B, S is assumed to be 4 for 
analytes with molecular weights of 100 to 500 Da; F is flow rate and Vm is the column 
dead volume, which can be directly measured or calculated from t0 by:  
Vm =t0F ≈ 5x10-4Ld2c                                                                                  Equation 5 
where L is column length (mm) and dc is column internal diameter (mm). 
Chromatographic separation is controlled by adjusting experimental conditions to 
achieve 1≤ k/k* ≤ 10. If this is not possible, 0.5 ≤ k/k* ≤ 20 is acceptable. Retention 
time is used for identification of a compound in HPLC245,257. 
 
2. Selectivity 
Selectivity is the separation factor (α) between two peaks and calculated 
as245,257:   α = k2/k1                            Equation 6 
Where k2 is the retention factor of the second peak and k1 the retention factor of the 
first peak. 
 
3. Resolution 
Resolution (Rs) measures the distance of separation between two peaks and is 
the chief objective of method development, particularly for the peak pair (critical peak 
pair) with the lowest separation (critical resolution). Baseline separation is necessary 
for accuracy of quantitative analysis and therefore resolution ≥ 2 is desired. If this is 
unachievable, resolution ≥ 1.5 is accepted245,257. Chromatographic selectivity and 
efficiency control resolution by increasing distance between the peaks and reducing 
peak width respectively. Rs is calculated: 
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Rs = 2 (tr(2) - tr(1))          Equation 7 
  Wb(1) + Wb(2) 
 
Where tr(2) is the retention time of the second peak; tr(1) is the retention time of the first 
peak; Wb(1) and Wb(2) are the peak widths at baseline for both peaks respectively. 
 
4. Efficiency 
Chromatographic efficiency is defined by the plate number (N) which measures 
peak width compared to its retention time by the equations245: 
  N = 16 (t2r)          Equation 8        or  H = L         Equation 9 
    Wb                                                                              N 
          
Where efficiency is measured per meter column with H as plate height and L as the 
column length. 
Band broadening is controlled by retention times and peak widths, influenced by three 
effects summarized in the Van Deemter equation and illustrated in Figure 11: 
H = A + B/u + Cu                        Equation 10 
Where A is the effect of column 
packing, B is the effect of longitudinal 
diffusion as analyte molecules pass 
along the column and C is the effect of 
resistance to mass transfer due to 
analyte affinity between the mobile 
phase and stationary phase that 
dictates its retention in either phase. 
Mobile phase velocity (flow rate) affects plate efficiency due to the differing 
relationships with each effect, A is independent, B is inversely proportional while C is 
directly proportional.  
 
5. Tailing Factor 
Peak asymmetry affects the separation between two peaks and is evaluated by 
tailing factor. A tailing factor of 1.0 demonstrates good peak separation, > 2 indicates 
potential problems with separation and creates difficulties for peak integration in 
quantitative analysis245,255. 
 
Figure 11. Graphical representation of Van Deemter's 
equation320 
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2.2.3 Optimization of Chromatographic Separation 
Method development focuses on the relationship between plate efficiency, 
selectivity and retention factor and their contribution towards chromatographic 
separation (resolution), described by the Purnell equation245,255,257: 
Rs = (√N/4) (α-1/α) (k2/1+k2)       Equation 11 
Systematic adjustment is conducted to optimize each condition until the critical 
resolution is Rs ≥ 2. Table 4 summarizes the typical chromatographic condition 
adjustments and their effect in retention factor, selectivity and efficiency, which helps 
to focus experimental investigations during method development and optimization. 
The different effect on retention factor and selectivity between isocratic and gradient 
elution due column length and flow rate results from the change in %B unless gradient 
time is changed proportionally to maintain same conditions245. 
 
Table 4. Effect of selected chromatographic separation conditions on retention (k/k*), selectivity (α) 
 and plate number (N)245 
Chromatographic Condition Effect 
k α N 
Column     
Stationary phase Minor,  major small 
Column length Isocratic: no effect  
Gradient: major 
Isocratic: no effect  
Gradient: major 
major 
Particle size no effect no effect major 
Mobile Phase    
%B major minor small 
Organic solvent minor major small 
pH for ionizable analytes major major minor 
Buffer concentration for ionizable analytes minor minor small 
Flow rate Isocratic: no effect  
Gradient: major 
Isocratic: no effect  
Gradient: major 
minor 
Temperature minor minor minor 
 
2.3 Capillary Electrophoresis (CE) 
 
  CE is a separation technique based on differing analyte electrophoretic 
mobilities (resulting from charge to mass ratio) as charged ions in a capillary under the 
influence of high electric field and background electrolyte (BGE). Compound migration 
is also controlled by the electroosmotic flow (EOF) induced in the electrolyte by the 
electric field, that carries analytes towards the detector258. The technique was developed 
by substantive innovation of Tiselius’s work in the 1980s and 90s 259.  
  CE is comparable to HPLC in versatility, capacity to separate analytes of 
varying physico-chemical properties and flexibility in instrument parameters and 
experimental conditions. Furthermore, the same detectors used in chromatography can 
be coupled to CE instrumentation. Several specific techniques exist based on separation 
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mechanism 246,260. It has significant advantages over the chromatographic techniques 
including potentially faster separations, lower reagent and consumable consumption, 
smaller sample demand (typically nL injected), less waste, use of a single capillary to 
separate different samples, better separation of enantiomers and simpler equipment. 
Additionally, detection at low wavelength (190-200 nm) is possible with the short 
capillary path length, allowing direct detection of acidic analytes without the 
derivatisation required in gas chromatography. Therefore, it has good potential in small 
organic and inorganic compound analysis246,258,261,262. The significant shortcomings in 
comparison to chromatographic techniques are poorer precision as result of migration 
time variance and method sensitivity (detection and quantification limits) resulting from 
small injection volumes and short capillary path length (defined by µm internal 
diameter). Precision is generally corrected using internal standards, while off-line (such 
as SPE) and online-preconcentration is applied to improve method sensitivity 246,247,263–
265. 
  Figure 12 shows a representation of a typical system. The sample is injected 
into the capillary, followed by the electrolyte (from its reservoir). Electrodes apply 
voltage to create the electric field, charging the analytes which migrate by their own 
mobility and are also carried by the EOF. In normal voltage polarity, EOF flow moves 
from injection at the anode (positive) to detection at the cathode (negative), in inverted 
flow, the charges of the electrodes are reversed. Analyte response is generated and 
displayed as an electropherogram. Hydrodynamic (with pressure) or electrokinetic (with 
voltage) injection can be performed. The former is preferred to reduce the bias problem 
that plagues electrokinetic injection, which works based on analyte electrophoretic 
mobility and EOF266. Figure 13 shows the important factors that affect CE separation. 
 
Figure 12. Schematic representation of a CE system showing ion separation by mass and charge and 
generated electropherogram321 
R1, R2 – electrolyte 
containers 
e1, e2 – electrodes 
F- power supply 
D-detector 
V- radiation source 
C- computer 
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Capillary zone electrophoresis, also called free solution, is the simplest CE 
method. Analyte separation is determined by BGE composition (buffer 
concentration/ionic strength, solvent, additives), pH and experiment conditions 
(temperature, voltage) that control EOF and analyte electrophoretic mobility. Voltage 
is applied with caution as high values can induce Joule effects (heating) through the 
capillary. This alters electrolyte viscosity and EOF, causing deterioration in separation 
and the sample, non-reproducibility, solvent boiling and cessation of analysis260,267. 
Mobility calculations from theoretical equations is difficult, therefore the values are 
derived from experiments to measure analyte migration time and EOF marker with267: 
Electrolyte electroosmotic flow (veo), cm/s = Length to detector (Ldet)    Equation 12 
                                                                        Time of EOF marker (teo) 
Equation 13 
Electrolyte electroosmotic mobility (µeo), 10
-5cm2V-1 s-1 = veo x Total length (Ltot)     
                                                                                             Applied voltage (V) 
 
Analyte apparent velocity (vap), cm/s= Ldet        Equation 14 
                                                              Analyte migration time (tap) 
 
Analyte effective velocity (vef), cm/s= vap - vap                                                                    Equation 15 
 
Analyte effective mobility (µef), 10
-5cm2V-1 s-1 = vef x Total length (Ltot)    Equation 16 
                                                                                Applied voltage (V) 
Capillary Electrophoresis
Capillary
Electrolyte
Analyte
 
Properties 
Coated/ uncoated 
Dimensions 
Length 
Internal diameter 
 
Buffer type and concentration 
Organic solvent and percentage 
pH 
Percentage of organic solvent 
Voltage applied 
EOF 
Surfactant type and concentration 
 
Physico-chemical properties 
Molecular structure 
Charge 
Electrophoretic mobility 
Figure 13. Important factors for CE separation 
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A response function can be calculated from the effective mobilities to identify 
the best pH for separation. The effective mobilities of each compound are organized in 
increasing value at a specific pH (0 to 12). The product of the difference between 
adjacent effective mobilities and the difference between maximum and minimum 
effective mobilities were calculated. The response function was determined at each pH 
by dividing the product by the difference. The maximum response function 
corresponds to the best pH for separation. The effective mobility curves for each 
compound and response function was plotted as a function of pH as shown in Figure 
30. The maximum value for response function occurs at pH 5. 
CE migration time is equivalent to HPLC retention time and also used for 
compound identification. EOF time (teo) is the migration time of a neutral solute or the 
solvent marker (first significant baseline disturbance). Resolution, tailing factor and 
efficiency is also used to evaluate quality of CE separation268,269.  
1. Capillary 
Narrow bore fused silica (silicon dioxide) capillaries are commonly used, with 
internal diameters of 25 –200 µm and length of 50 –100 cm for the benefits of precision, 
low electrical conductivity, high thermal conductivity, mechanical resistance and optical 
transmission over a wide UV range. Capillaries are conditioned when first prepared and 
before analysis with sodium hydroxide, followed by milli-q water and finally the 
electrolyte, to ensure the surface is uniformly and fully charged and to remove any 
residue from previous experiments respectively. Electroosmosis occurs due to analyte 
interactions with the weakly acidic silanol groups on the capillary wall surface, with 
some groups dissociating in the aqueous electrolyte to give negative charge to the 
capillary wall. The inner capillary wall can be chemically modified to change analyte 
interactions. Joule effects are controlled by the large ratio between the internal surface 
area and volume and high electrical resistance of the silica material260,267. 
2. Background Electrolyte 
The BGE is necessary to transport and separate samples in the electric field270. 
Buffer concentration controls EOF flow by changing analyte adsorption to the 
capillary wall. Buffer type affects band tailing and symmetry by closeness of 
electrolyte mobility to anion mobility. pH controls analyte ionization and resulting 
electrophoretic mobility as a product of the distribution and relative concentrations of 
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ionic and neutral form and degree of ionization of silanol groups on the capillary 
surface. These conditions are therefore selected considering analyte molecular 
structure and physico-chemical properties that influence behaviour in buffer of choice 
and give desired separation, while avoiding heat close to Joule effects, band distortion 
and broadening and erratic EOF which reduces migration time reproducibility258,271. 
Low buffer absorption at analytical wavelength should be observed. High pH buffers 
such as borate are recommended for acidic compound separation such as ibuprofen and 
the metabolites, which are converted to anions at these pHs with effective mobilities 
that allow fast separation246. The application of high electric field gives high separation 
efficiency, resolution and short analysis time through control of EOF flow258,260,267,270.  
Additives such as organic solvents (methanol, acetonitrile and tetrahydrofuran) 
and surfactants are added to BGEs to alter EOF flow (reduce, increase, invert or 
suppress), analyte electrophoretic mobility, electrolyte viscosity, solubilize analytes 
and analyte adsorption to the capillary wall258,260,272. However, it is recommended to 
limit maintain organic solvent to < 40%, otherwise contradictory results, erratic 
migration times and electric breakdown can occur228.  The effect of EOF control and 
voltage polarity on the migration of anions is depicted in Figure 14 and are considered 
when selecting the appropriate CE experimental conditions258,273. Figure 14A shows 
possible separation of slow anions (eg. aromatic compounds) whose smaller mobility 
(vef) is overwhelmed by that of the EOF (vosm) and carried towards the cathode. In 
contrast, fast anions (such as inorganic and short chain carboxylic acids) migrate 
towards the anode, away from the detector, leaving the capillary. Figure 14B is 
possible for rapid anions although analysis time is lengthened, due to their migration in 
counterflow to the EOF. Figure 14C presents the use of a surfactant and further 
discussed in Section 2.3.1. The separation in Figure 14D is a result of special inner 
lined capillaries however, the analysis time is long. 
 
 
 
 
 
 
 
 
35 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.3.1 Micellar Electrokinetic Capillary Chromatography  
 
Micellar electrokinetic capillary chromatography (MEKC) employ surfactants 
in BGEs to alter the EOF by formation of a micelle dispersed (secondary) phase 
moving at a different velocity to the electrolyte (primary phase). When an electric field 
is applied, charged (acidic and basic) and neutral compounds are separated by 
differences in electrophoretic movement, solubility-based partitioning and ion pair 
interaction with the charged micelle246,260,274.  
The surfactants (micelles) are amphiphilic molecular aggregates possessing 
long hydrophobic tails and polar heads, ranging from anionic (e.g. sodium lauryl 
sulphate, SDS), cationic (e.g. cetrimonium bromide) to neutral. Their properties 
determine individual effect on the EOF (reduce, reverse, suppress) and analyte 
mobility due to hydrophobic and electrostatic interactions. Concentration in the 
electrolyte determines the magnitude of their effect, hence its likeness to reverse phase 
chromatography and should be used above critical micellar concentration to promote 
rapid, stable formation and dynamic equilibrium. Analyte selectivity in MEKC is 
determined by the surfactant selected, buffer type (analyte, its electrophoretic mobility 
and electrolyte interactions), pH (migration faster as pH increases) and temperature 
(solubility, equilibrium and kinetics)246,260,274. 
Figure 14. Schematic representation of anion migration in 
different CE EOF  
Inverted polarity 
Inverted polarity 
Normal polarity 
Inverted polarity 
Inverted eof 
Suppressed eof 
detector injection 
(A) normal EOF with normal polarity (B) normal EOF with inverted polarity (C) EOF inverted by 
cationic surfactant and inverse polarity (D) suppressed EOF and inverted polarity258 
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Figure 14C depicts the MEKC mechanism with a cationic surfactant, which 
adsorps to the capillary wall, leading to dispersion and the establishment of a two 
dimensional semimicelle structure on the capillary wall surface. The positive heads of 
the surfactant face the electrolyte, creating a diffuse electric double layer from the 
anions which position at the surface-solution interface. When the electric field is 
applied, the EOF flow is inverted with migration extending through all layers, causing 
anion movement towards the anode by electrophoresis and electroosmosis258. MEKC 
using SDS, has been used in ibuprofen in analysis of pharmaceutical products237,238,275.  
2.3.2 On-line Preconcentration: Stacking 
Off-line or on-line preconcentration 
techniques can be used to resolve method 
detection limit problems in CE276–280. 
Extraction methods form the basis of off-
line procedures such as solid phase 
extraction (SPE)240,281. On-line 
preconcentration techniques include 
stacking by ionic strength, pH, large 
volume and field amplified. Large volume 
and field amplified modes have been 
applied to ibuprofen analysis230,242,282 or 
off-line and on-line techniques have been 
combined279 to improve method 
sensitivity such as field amplified and 
SPE techniques243,283. Field-amplified 
sample stacking (FASS), the simplest 
approach, is a result of conductivity 
differences between the sample solution 
and BGE. Hydrodynamic injection of the 
low conductivity sample (prepared in 
dilute buffer or water) into the capillary 
with high conductivity BGE results in the higher application of the electric field on the 
sample zone in comparison to the BGE. This results from the inverse proportion of 
electric field strength to electrical conductivity. The electrophoretic mobility of ionized 
Figure 16. Schematic representation of FASI  
 (a) introduction of short plug of water into the capillary, 
followed by sample injection under negative voltage. 
(b) Separation with high conductivity buffer and normal 
polarity286 
Figure 15. Schematic representation of FASS (a) 
immediately after voltage application (b) after stacking is 
completed318 
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analytes is therefore faster in the sample zone and they move with high velocity 
towards the boundary of sample and BGE. At the boundary, the low field strength 
decreases their velocity decreases, creating the build-up of the analytes (stacking) at 
the boundary of sample and BGE (Figure 15). By increasing the injection time of the 
sample, increase in sensitivity up to 100 fold can be achieved277. Field-amplified 
sample injection (FASI) builds on FASS by injecting a water plug hydrodynamically, 
followed by the electrokinetic injection of the sample to provide a high electric field 
strength as shown in Figure 16. For anions, the injection is performed with reverse 
polarity, then switched to normal polarity for separation284–286.  
2.4 HPLC and CE UV/Vis Detectors 
 
The UV/Vis detectors used in HPLC and CE instrumentation (general operating 
range 190 - 600 nm) directly measure analyte responses, following Beer’s Law that 
absorbance is directly proportional to analyte concentration245. The detectors are 
sample specific, measuring the response of compounds that absorb at a specific 
wavelength. The customary light sources are deuterium, mercury and tungsten lamps 
as fixed wavelength, diode array (spectrum) or variable wavelength. These detectors 
are applicable to a vast range of compounds except for those with no UV activity (e.g. 
sugars). Mobile phase and BGE solvents must be selected so that they do not absorb at 
the detection wavelength and are mistaken for the target analyte. Determining the 
analyte absorption maximum is useful to pinpoint detection range, however 
experiments during method development can decide the selection of final method 
detection wavelength, based on observed strength of absorbance, sensitivity increase or 
decrease, visibility of other compounds in sample and signal to noise ratio245. 
Detector optic configuration differs between instruments and manufacturer in 
the type of UV/Vis light source (such as deuterium, mercury, tungsten), use of multiple 
lamps, addition of filters (holmium oxide) or UV selecting filters.  
2.5 Experimental Design 
 
Experimental design is used for the simultaneous evaluation of multiple factors 
at a selected number of levels in a defined number of experiments287. It is extremely 
valuable to best experimental conditions by evaluation of the whole experimental 
domain, detect the significant factors and their influence on the response of critical 
method variables288. It avoids inefficient trial and error investigations or monitoring 
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one variable at a time that consumes time and resources and prevent consideration of 
the interactive effects. Experimental design is gaining popularity as useful tool in 
pharmaceutical and environmental method development287–290, particularly for sample 
preparation, instrument and method conditions for analyte separation289. 
Experimental designs can be classified as screening designs such as full 
factorial (Table 5) 291,292, response surface and mixture designs. Screening designs are 
used to identify the most significant factors on response variables and may be used to 
select their optimal levels. Response surface designs help to determine optimal level, 
while mixture designs investigate factors as a fraction in a mixture287,290. The 
appropriate design is selected depending on desired information, number of factors to 
be studied, operational and resource availability and ability to implement the chosen 
design291. Preliminary experiments are conducted to identify the significant response 
variables for evaluation of method performance, the factors and the levels to be 
investigated291. The responses are evaluated by response functions293 or other statistical 
tests such as analysis of variance290,291. Common HPLC variables investigated are 
mobile phase composition, flow rate, temperature and pH while investigated CE 
variables include BGE composition, pH, separation voltage and additives 287.  
Table 5. Full factorial screening designs and their parameters 
Design Factors Number of 
experiments 
Type Number of factors (k)  
Two-level full factorial Numerical categorical 2 ≤k≤5 2k 
 
2.6 Chromatographic Response Functions 
 
The quality of chromatographic separations can be evaluated and classified 
using response functions based on separation goal of the developed method. The 
commonly used response functions are chromatographic resolution statistic (CRS), 
chromatographic response function (CRF), chromatographic exponential function 
(CEF), resolution sum (Rsum), resolution of critical peak pair (Rcp) and number of 
resolved peaks (RP)293–296. Originally developed for HPLC, the functions have been 
applied to CE295  and are defined as: 
                                                                 Equation 17 
 
                                       Equation 18 
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                          Equation 19 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
Equation 20 
                                                                                                                                         
Where np is the number of peak pairs, Ri, i+1 is resolution between adjacent solute pairs, 
Ropt is the optimum resolution, Rmin is the minimum acceptable resolution, Rm is the 
average resolution of all solute pairs, tf is the migration time of final solute, n is the 
number of solutes in the sample. tmax is the maximum desired runtime, tmin is the 
minimum desired runtime, tf is the migration time of final solute, ti is the migration time 
of first solute, σ1, σ2, σ3 are user selected adjustable weights (σ1 = 3, σ2 =2, σ3 = 1). 
These multi-variate functions allow the ranking of electropherogram results by 
evaluation of separation resolution, retention time, separation time and uniformity of 
peak distribution to select the optimal conditions for separation. Large Rsum values are 
obtained from electropherograms with well resolved solute pairs. The smallest CRS 
and CEF value indicates those with the best resolved peaks while the largest CRF 
indicates the electropherograms with the best separation conditions. The CEF improves 
on the CRS by reducing sensitivity to peak pairs with resolution larger than the desired 
maximum and emphasis on separation time unless the desired maximum is exceeded. 
The response functions offer an simpler alternative to chemometric software in 
the event of unavailability in the laboratory or due to small number of analytes in a 
sample and simple separation conditions. 
 
2.7 Solid Phase Extraction (SPE) 
 
Sample preparation is the fundamental basis of accurate and precise analysis, 
from point of collection to instrument analysis245. SPE (manual or automated) is a 
prevalent sample preparation method in environmental pharmaceutical analysis for 
several advantages. It is a facile, highly efficient, robust, economic, versatile technique 
with low organic solvent consumption. It removes the target analyte from the matrix of 
study, minimizing the possible effects of interferences and enhancing selectivity in 
analytical methods. Finally, trace analyte concentrations usually found in the 
environment are enriched to levels detectable by the method and measuring 
instrumentation5,55,245,252,257.  
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SPE works by same principles as HPLC. The differing affinities between the 
functional groups of the target analytes and those of the SPE sorbent are enhanced or 
decreased through critical factors that must be considered in developing and selecting 
an SPE procedure. These factors include sample pre-treatment, sorbent type (silica, 
polymeric) and the solvents for conditioning, washing and elution. SPE conditions are 
chosen upon evaluation of the physico-chemical properties of the target analytes (pKa, 
polarity, structure, hydrophobicity), expected analyte concentration, matrix 
composition and objective of the SPE procedure257,297. The typical SPE procedure 
performed under vacuum, consists of the following typical steps (Figure 17)257,297: 
1. Conditioning: the passage of an appropriate solvent, typically methanol or 
acetonitrile, is used to solvate the sorbent and remove any impurities. Water is then 
passed through the cartridge to remove the conditioning solvent. 
2. Retention: the analyte solution 
is loaded and passed through 
cartridge where the target 
analytes are retained.  
3. Washing: Interferents are 
removed by rinsing with an 
appropriate solvent of 
intermediate strength. The 
solvent can be water or organic 
solvent/ water. The latter is 
used if water only is insufficient and the amount of organic solvent is controlled to 
remove the interferences but not lose the target analyte.  
4. Elution: appropriate solvent of appropriate strength (e.g. methanol, acetonitrile, 
water or buffer) strong enough to recover the target analytes from the SPE sorbent.  
Additional steps that can be employed are: 
1.  Sample pre-treatment: sample solution properties can be changed via a pH 
adjustment or other additives to suppress analyte ionization and maximize the 
selectivity of the target analytes to the SPE sorbent in the retention step. 
2. Drying: This can be performed after the washing step using vacuum or heat to 
ensure the complete removal of the wash solvent and any interferences. 
Retention 
Figure 17. Schematic representation of typical SPE procedure297 
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3. Drying of elution and reconstitution: the elution can be dried by vacuum 
concentration or evaporation and the extracts reconstituted in a weaker solvent that 
is more compatible with the analytical methods.  
Off-line or online SPE using silica based or polymeric sorbents is the most 
prevalently method for pharmaceuticals 60,297. Literature review reveals several SPE 
methods developed and validated for ibuprofen and the metabolites, which can be used 
in this study. The best recoveries were obtained with the following SPE conditions: 
Sample pretreatment: pH of all aquatic matrices (surface, ground, wastewater) is 
adjusted to the acidic range (pH 2 -3)22,27,29,72,147,212,240,298,299 to ensure the acidic 
compounds remain in neutral form.  
Sorbent: Reversed phase silica C18 and polymeric sorbents such as Oasis HLB, Oasis 
MCX and Strata-X are most commonly applied. These non-polar sorbents display 
selectivity with the hydrophobic compounds via nonpolar-nonpolar and van der Waals 
interactions257,297. The narrower pH stability range of the C18 sorbent (pH range 2-8) 
slightly reduces its versatility in comparison to polymeric sorbents (pH range 0-14)297. 
Studies comparing the performance of C18 and polymeric sorbents, found that for 
ibuprofen, generally the recoveries obtained from different sorbents was similar72,299 
Kot-Wasik et al compared three C18 sorbents to Strata-X. The results showed that 
comparable recoveries between the C18 and polymeric sorbents, therefore either can 
be used. The use of polymeric sorbents is generally seen when ibuprofen is analysed 
with other pharmaceuticals and not as a single compound27,29,57,72,147,212,298,299. 
The drawbacks of off-line SPE in time consumption and possible analyte loss 
during elution and elution drying, has not reduced its popularity as a simple, 
economical and flexible technique compared to the complexity of on-line SPE297.  
2.8 Internal Standard Calibration 
 
Internal standard calibration uses a compound with external reference standards 
and the samples of study. It compensates for possible effects of errors from sample 
pre-treatment or instrumentation conditions. The chosen compound must have similar 
structure, physico-chemical properties and behaviour in the analytical method, but 
separate quantification and elution is possible and it is absent from the sample of study. 
Regression analysis is performed for a calibration curve, prepared by plotting the ratio 
of analyte signal to internal standard signal as a function of analyte concentration. 
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Analyte concentration in sample solutions is calculated using the obtained  linear 
equation 300.  
In this study, internal calibration is used to 
compensate for any losses during the sample pre-
treatment and processing in SPE and the possible 
variances in analyte migration time common to CE300,301. 
Benzoic acid (BA) was chosen as the internal standard 
due to its classification in the same class of compounds 
(carboxylic acids) and similar pKa (4.19) as IBU, 1OH, 2OH and CBX302,303. BA 
therefore shares similarity in structure (Figure 18) and behaviour in the HPLC mobile 
phase (neutral at acidic pH) and CE background electrolyte (ionized to anionic form at 
basic pH) and is absent in the samples of study. It is recommended as an CE internal 
standard for acidic compounds to prevent effects from interactions301. The SPE extracts 
of standard and sample solutions were spiked with the same amount of BA during 
reconstitution for HPLC and CE analysis. 
2.9 Method Validation 
Laboratories must demonstrate that methods of analysis are suitable for their 
intended application by method validation304,305. Several bodies such as the 
International Conference on Harmonization (ICH), the Association of Official 
Analytical Chemists International (AOAC) and International Standards Organization 
(ISO/IEC 17025: 2005) provide guidance for this process304–310. Validation parameters 
should be selected upon consideration of the physico-chemical properties and 
molecular structure of the analyte(s); concentration range in the sample; sample 
matrix; possible interferences; analytical purpose (quantitative or qualitative); required 
limits of detection and quantification; required precision and accuracy; required 
robustness; instrument capabilities; applicable legislation305,309–311. For this study, six 
parameters were chosen considering research purpose of the developed methods.  
2.9.1 Specificity 
 Specificity is the ability to identify the target analyte(s) in the presence of other 
components such as impurities, degradation products and matrix. It may be difficult 
due to sample matrix complexity, low analyte concentration, large number of analytes, 
similarity between the analyte and matrix or the analytes304,309–311.   
Figure 18. Structure of benzoic 
acid303 
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2.9.2 Linearity  
 Linearity is the ability to obtain results directly proportional to analyte 
concentration across the method range. A minimum of five standard concentrations 
evenly spanning 80-120% of the expected sample concentration range is 
recommended. A minimum number of three replicate injections is required for each 
concentration, however five to six injections are recommended304,309,310. 
 A two-fold evaluation is performed to assess the degree of linearity of the 
results. The first is visual inspection of response plotted as a function of analyte 
concentration. The second is statistical treatment of the results by linear regression 
(method of least squares) to generate a calibration curve and linear equation. The data 
may require previous mathematical transformation. The regression parameters of 
correlation coefficient (r), y-intercept (a), slope of regression line (b) and residual sum 
of squares are also provided. Standard deviation (SD) or variance (CV) of the results of 
the standard solution series should be assessed before construction of the calibration 
curve using the Hartley’s Fmax test (significance level of α = 0.05) to determine any 
significant statistical difference. If there is no statistical difference, the calibration 
curve can be plotted311. 
A correlation coefficient (r) ≥ 0.99 is accepted as good linearity. However, it is 
recommended to verify linearity by another method such as plotting the residuals (the 
deviation of the measured data points) versus the concentration. If the data fits the 
regression model, then the residuals will be randomly distributed around zero 292,304. 
  
2.9.3 Range 
The range is the interval between the lower and upper analyte concentrations 
expected in the sample, that give acceptable precision, accuracy and linearity. It is 
expressed in the same units as the measured results from the limit of quantification to 
the maximum standard solution concentration used for calibration304,310. 
2.9.4 Precision 
  Method precision is the closeness of agreement between a measurement series 
attained from multiple sampling from the same homogenous sample and is expressed 
as SD or CV of that series304,310. Three components can be considered: 
a. Repeatability (intra-assay precision): expresses the closeness between consecutive 
measurements under the same operating conditions (instrument, analyst, day, 
standard and reagent batch). At least six replications at 100% of test concentration 
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or nine determinations covering the specified method range, are recommended. The 
Dixon’s Q test (significance level of α = 0.05) is applied to detect outliers. Variance 
in results is assessed using the Hartley’s Fmax test (significance level of α = 0.05) to 
determine any significant statistical difference311. 
b. Intermediate precision: evaluates the possible effects for normal variations within a 
laboratory such as different days, analysts, equipment, manufacturers and batches of 
standards and reagents to reveal potential problems with method. 
c. Reproducibility: evaluates precision between laboratories through collaborative 
studies for method standardization, interlaboratory and proficiency tests.  
2.9.5 Limit of Detection 
  The limit of detection (LOD) is the minimum amount of analyte that can be 
reliably detected. It can be determined as follows304,310: 
a. Visual Inspection: analysis of samples of known analyte concentrations (standard 
in solvent or matrix) to establish the minimum level for confident detected.  
b. Signal to Noise ratio: determined by comparison of measured sample signals of 
known low analyte concentration with signals of blank samples to establish the 
minimum concentration that gives a ratio of 3.  
c. Standard Deviation of the Blank: determined from the average and standard 
deviation from 10 independent measurements of 10 independently prepared blank 
samples to obtain the magnitude of the analytical background response. 
d. Standard Deviation of the Response based on the Calibration Curve Slope: a 
calibration curve is prepared using the measured responses (at least five replicate 
injections are recommended) of the three lowest analyte concentrations used to 
determine linearity. LOD is determined as the mean of the LOD determined from 
residual standard deviation of regression line and the LOD determined from 
standard deviation of the y-intercept using: 
 
LOD from residual standard deviation = 3.3residual SD                      Equation 21 
                                                                             b 
 
LOD from standard deviation of the y-intercept = 3.3 y-intercept SD   Equation 22 
                                                                                          b 
 
The accuracy of the calculated LOD is accepted if 10 times the value is greater 
than the lowest standard concentration (condition 1) and if the value is smaller than 
the lowest standard concentration (condition 2). If the LOD fails to meet condition 
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1, the concentrations in the standard solutions were too high and should be remade 
with lower concentrations. If condition 2 is failed, the concentrations were too low 
and should be remade with higher concentrations311. 
2.9.6 Limit of Quantification 
  The limit of quantification (LOQ) is the minimum amount of analyte that can 
be reliably quantified with appropriate precision and accuracy304,310. LOQ can be 
determined from the same approaches used LOD. The acceptance criteria for signal to 
noise ratio is 10:1 or LOQ can be determined from the standard deviation of the 
response based on the calibration curve slope using the calculated LOD value: 
LOQ = 3 x LOD                    Equation 23 
2.9.7 Accuracy 
 Accuracy is the closeness of agreement between the accepted value taken as the 
conventional accepted reference value and the measured value. It can be assessed 
using several approaches including extracting analyte from a matrix and comparing 
the measured response that from the reference material dissolved in pure solvent to 
determine the amount recovered. Assessment should cover the method range by 
selecting concentrations close to the LOQ, the middle and high concentration of the 
calibration curve. A minimum of three concentrations with a minimum of three 
replicates (nine determinations) is recommended. The parameter is reported as percent 
recovery by the assay of the known added amount of analyte or as the difference 
between the mean and accepted true value with confidence intervals304,310. 
2.9.8 Robustness 
  The parameter is the capacity to withstand small, deliberate variations in the 
method parameters and maintain reliability during routine use304,310. This is considered 
during development phase.  
 
2.10 Statistical Analysis  
2.10.1 Student’s t-test 
 
Student’s t test compares the means of two series of results and calculated as: 
   
                                                                                                                                                                                                     
Equation 24 
 
Where x1m and x2m are the means for both series of results, SD1 and SD2 are the 
standard deviations. The calculated t (tcal) is compared to the applicable critical value 
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(tcrit) in the table of critical values of student’s t test (Annex 1a), at significance level (α 
= 0.05) and the number of degrees of freedom (f = n1+n2 - 2). If tcal < tcrit, there is no 
statistically significant difference between the means of the compared series of results 
is accepted. If it exceeds, there is a statistical difference290,292,311. 
 
2.10.2 Hartley’s Fmax Test 
 
The Hartley’s Fmax test compares the standard deviations or variances of two or 
more series of results using: 
Fmax =  CV
2
max        Equation 25 
            CV2min 
 
Where CV2min and CV
2
max are the smallest and largest coefficients of variance. The 
Fmax value is compared to the applicable critical value (Fmaxo) in the table of critical 
values of Hartley’s Fmax test (Annex 1b), at selected significance level (usually α = 
0.05), calculated number of degrees of freedom equivalent to the number of results (f = 
n-1) and the number of compared series. If Fmax < Fmaxo, there is no statistically 
significant difference between the standard deviations of the compared series of 
results. If it exceeds, there is a statistical difference311,312. 
2.10.3 Dixon’s-Q Test 
 
The Dixon’s-Q test is used to detect outliers within a series of results. The 
results are arranged in increasing order smallest value (x1) to largest value value (xn) 
and the parameters of range R, Q1 and Qn calculated from the following equations: 
R = xn - x1         Equation 26 
Q1 =  x2 - x1          Equation 27 
            R 
 
Qn =  xn – xn-1         Equation 28 
               R 
 
Q1 and Qn are compared to the applicable critical value (Qcrit) in the table of critical 
values of Dixon’s Q test (Annex 1c), at the selected significance level (usually α = 
0.05) and the number of degrees of freedom equivalent to the number of results (f = n). 
If Q1 and Qn do not exceed Qcrit, there is no outlier within the results. If they exceed, an 
outlier is present290,292,311. 
 
47 
3. Materials and Methods 
 
3.1 Reagents and Materials 
The reagents and materials used at each university is presented as follows: 
3.1.1 Reagents 
Universidade do Algarve (UAlg) 
HPLC 
Acetonitrile (≥99.8% HiPerSolv CHROMANORM) was purchased from Fisher 
Scientific (Loughborough, UK). Sulphuric acid (96%), ammonium chloride and 
glacial acetic acid were purchased from Panreac Applichem (Barcelona, Spain). 
Methanol (≥99.8% HiPerSolv CHROMANORM) and ammonium acetate (Hipersolv 
for HPLC) were purchased from VWR International (Carnaxide, Portugal). 
 
Synthetic Wastewater 
Sodium acetate (99%), iron sulphate heptahydrate, potassium chloride, calcium 
chloride, manganese chloride tetrahydrate, monobasic potassium phosphate, 
ethylenediaminetetraacetic acid, sodium hydroxide, potassium hydroxide and dibasic 
potassium phosphate were purchased from VWR International (Carnaxide, Portugal). 
Zinc sulphate heptahydrate was purchased from Applichem Panreac Applichem 
(Panreac Quiminica SLU, Barcelona, Spain). Colbalt chloride hexahydrate, 
ammonium heptamolybdate tetrahydrate and copper sulphate pentahydrate was 
purchased from Riedel-de-Haen (Honeywell Specialty Chemicals Seelze, Germany). 
 
The organic solvents and ammonium acetate were HPLC grade. All other reagents 
were analytical grade. Milli-q water from a Merck Millipore Elix10 system (Merck 
Millipore, Madrid, Spain) was used for all reagent and standard preparation. 
 
Universidade de São Paulo (USP) 
HPLC 
Methanol (Chromasolv, ≥99.9%), acetonitrile (Chromasolv, ≥99.9%), glacial acetic 
acid, formic acid (≥ 96%) were purchased from Sigma Aldrich Chemie Gmbh 
(Munich, Germany).  
CE 
Sodium tetraborate decahydrate and acetonitrile (Chromasolv, ≥99.9%) were 
purchased from Sigma Aldrich Chemie Gmbh (Munich, Germany). Sodium dodecyl 
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sulphate was obtained from Sigma Aldrich (St. Louis, MO, USA). Tetrahydrofuran 
(THF) was procured from Tedia Company Inc. (Fairfield, OH, USA). Cetrimonium 
bromide was purchased from Sigma Aldrich (Milwaukee, MI, USA).  
 
Synthetic Wastewater 
Sodium acetate was procured from Anidol Products (São Paulo, Brazil). Magnesium 
sulphate heptahydrate was acquired from Cromato Productos Quimico (São Paulo, 
Brazil). Potassium chloride, iron sulphate heptahydrate and ammonium 
heptamolybdate tetrahydrate were obtained from Lab Synth Products (São Paulo, 
Brazil). Ammonium chloride and benzoic acid were purchased from Carlo Erba Do 
Brazil (São Paulo, Brazil). Ethylenediaminetetraacetic acid and dibasic potassium 
phosphate were purchased from Mallindrodt (St. Louis, MO, USA. Monobasic 
potassium phosphate was purchased from F. Maia Ind e Comerico (São Paulo, Brazil). 
Zinc sulphate heptahydrate was procured from J.T Baker Chemical Co (NJ, USA). 
Calcium chloride and potassium hydroxide were obtained from Cinetica Quimica Ltd 
(São Paulo, Brazil). Manganese chloride tetrahydrate and colbalt chloride hexahydrate 
were purchased from Vetec Quimica Fina LTDA (Rio de Janiero, Brazil). Copper 
sulphate pentahydrate was purchased from Regen Industris Quimicas (Rio De Janiero, 
Brazil). Potassium hydroxide and sodium hydroxide were purchased from Merck 
Chemicals Ltd (São Paulo, Brazil).  
 
SPE 
Concentrated hydrochloric acid (HCl) was purchased from Lab Synth Products 
(Diadema, São Paulo, Brazil). 
 
The organic solvents were HPLC grade, all other reagents were analytical grade. 
Milli-Q water from a Merck Millipore Milli-Q system (Merck Millipore, São Paulo, 
Brazil) was used for all reagent and standard preparation. 
3.1.1.1 Reference Standards 
Ibuprofen (certified reference material, purity 99.7%), 1-hydroxyibuprofen 
(pharmaceutical impurity standard, purity 99.7%), 2-hydroxyibuprofen (VETRANAL 
analytical standard, purity 99.3%), carboxyibuprofen (VETRANAL analytical 
standard, purity 99.0%) were purchased from Sigma Aldrich (Sintra, Portugal). 
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3.1.2 Materials 
3.1.2.1 SPE 
Strata C18e (200 mg, 6mL) SPE cartridges were obtained from Phenomenex 
(Torrance, CA, USA).  
3.1.2.2 Characterization of Reactor Influent and Effluent 
 
COD, phosphorus, total nitrogen and ammonia were measured using LANGE 
commercially available kits supplied by HACH (Carnaxide, Portugal). The kit 
specifications are given in Table 6.  
 
Table 6. Parameters and kits used for characterization of the SBR influent and effluent 
Parameter measured Kit Concentration Range* 
(mg/L) 
Ammonium (NH4-N) LCK 304 0.015–2.0 
COD LCK 514 100-2000 
Nitrate (NO3-N) Powder pillows, cadmium 
reduction method – 8039 
0.3-30.0 
Phosphorus (PO43-)  USEPA Phosver3® (ascorbic 
acid) method 8048 
0.02-2.50 
                *Indicated by manufacturer 
 
3.1.3 Experimental Preparation  
3.1.3.1 Synthetic Wastewater Preparation 
 Synthetic wastewater was prepared using two media to simulate typical 
characteristics of sewage wastewater. Media A was composed of sodium acetate (63 
mM), magnesium sulphate heptahydrate (3.6mM) and potassium chloride (4.7 mM). 
Media B was composed of ammonium chloride (35.4 mM), dibasic potassium 
phosphate (4.2 mM), monobasic potassium phosphate (2.1 mM) and 10 mL/L trace 
element solution164. The trace element solution was prepared using 
ethylenediaminetetraacetic acid (50.0 g/L), zinc sulphate heptahydrate (22.0 g/L), 
calcium chloride, calcium chloride (5.54 g/L), manganese chloride tetrahydrate (5.06 
g/L), iron sulphate heptahydrate (4.99 g/L), ammonium heptamolybdate tetrahydrate 
(1.10 g/L), copper sulphate pentahydrate (1.57 g/L), colbalt chloride hexahydrate 
(1.61 g/L) and adjusted to pH 6 using potassium hydroxide313. Finally, 150 mL of 
each media was mixed with 1300 mL of tap water164.  
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3.1.3.2 Preparation of Reference Standards and Internal Standard 
  Individual compound primary stock solutions were prepared by weight at UAlg 
and USP, in methanol and acetonitrile respectively to solubilize the compounds 
according to the organic solvent tested in experiments. These solutions were stored at 
-200C for at least 3 months use, due to stability in organic solvent29,87. A series of 
reference standard solutions for this study were prepared from these individual 
primary stock solutions as represented in Figure 19 and described as follows for the 
work at each university 
 
UAlg 
  Working standard solutions (0.5 – 10000 μg/L) were used in method 
development and optimization experiments to determine compound retention time and 
selectivity, peak resolution and smallest concentration detectable on the HPLCs. 
Working standard solutions were used to prepare a calibration curve of range 50 – 500 
μg/L. The concentrations for all solutions, corrected for purity as provided by the 
manufacturer, are shown in Tables 7 and 8.  
Table 7. Actual concentrations of primary and intermediate standard stock solution and working standard 
solution 
Compound Weight 
(g) 
Primary stock solution 
concentration  
(μg/L) 
Intermediate stock 
solution concentration  
(μg/L) 
Working standard solution 
concentration  
(μg/L) 
IBU 0.0050 99700 9970 9970 
1OH 0.0050 99700 9970 9970 
2OH 0.0050 99300 9930 9930 
CBX 0.0050 99000 9900 9900 
 
100000 μg/L individual primary stock solutions  
1. 2OH 2. 1OH 3. CBX 4. IBU; 50 mL in methanol or acetonitrile 
Working standard solutions containing 
IBU, 2OH, 1OH, CBX 
UAlg: 20 mL in milli-q water and synthetic 
wastewater 
USP: 5 mL in milli-q water and synthetic 
wastewater 
10000 μg/L Individual intermediate stock 
solutions containing IBU, 2OH, 1OH, CBX;  
UAlg: 20 mL in methanol or acetonitrile 
USP: 25 mL in methanol or acetonitrile 
Standard solutions for calibration curve 
containing IBU, 2OH, 1OH, CBX 
1. Milli-q water 
2. Synthetic wastewater 
Figure 19. Schematic representation of reference standard solution preparation 
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Table 8. Preparation and actual concentrations of working standard solutions used in method development, 
optimization, calibration curve 
Standard 
Solution No. 
Volume from individual 
intermediate stock solution  
(mL) 
Theoretical 
concentration  
(μg/L) 
Actual concentration (μg/L) 
IBU 1OH 2OH CBX 
2 10 5000 4985 4950 4965 4985 
3 4 2000 1994 1980 1986 1994 
4 2 1000 997 990 993 997 
5 1 500 499 495 497 499 
6 0.2 100 98 99 99 98 
7 0.1 50 50 50 50 50 
8 0.05 25 25 25 25 25 
9 0.02 10 10 10 10 10 
10 0.002 1 1 1 1 1 
11 0.001 0.5 0.5 0.5 05 0.5 
 
USP 
  A series of reference standard solutions were prepared as shown in Figure 19. 
The actual concentrations for all solutions, corrected for purity as provided by the 
manufacturer, are given in Tables 9, 10 and 11.   
Table 9. Preparation of primary and intermediate standard stock solutions 
Compound Weight  
(g) 
Actual Primary stock solution 
concentration  
(μg/L) 
Intermediate stock solution 
concentration (μg/L) 
IBU 0.00500 99700 9970 
1OH 0.00501 99900 9990 
2OH 0.00500 99300 9930 
CBX 0.00500 99899 9990 
 
Table 10. Preparation of standard solution used in method development and optimization 
Standard 
Solution 
No. 
Volume from primary 
stock solution  
(μL) 
Theoretical 
concentration  
(μg/L) 
Actual concentration  
(μg/L) 
IBU 1OH 2OH CBX 
1 100 2000 1994 1998 1986 1980 
2 200 4000 3996 3988 3972 3960 
3 300 6000 5994 5982 5958 5940 
4 400 8000 7992 7976 7944 7920 
5 500 10000 9990 9970 9930 9900 
6 600 12000 11988 11964 11916 11880 
7 700 14000 13986 13958 13902 13860 
 
Table 11. Preparation of standard solution series for calibration curve 
Standard 
Solution 
No. 
Volume from primary 
stock solution  
(μL) 
Theoretical 
concentration  
(μg/L) 
Actual concentration  
(μg/L) 
IBU 1OH 2OH CBX 
1 7.5 15 15.0 14.9 14.9  15.0 
2 12.5 25 24.9 24.8 24.8 25.0 
3 25.0 50 49.9 49.5 49.7 49.9 
4 37.5 75 74.8 74.3 74.5 74.9 
5 50.0 100 99.7 99.9 99.3 99.9 
6 62.5 125 124.6 124.6 124.1 124.9 
 
Internal standard benzoic acid was prepared with final concentration of 100000 
μg/L by weighing 0.0100 g in 100 mL volumetric flask and making to volume in milli-
q water. 250 μL of this solution was added to standard solutions for a final 
concentration of 5000 μg/L. 
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3.2 Solid Phase Extraction 
SPE was performed with Strata C18e 200 mg/6mL cartridges using a vacuum 
manifold system connected to Fanem dia pump (Figure 20A). The procedure is 
described in Figure 20B. The procedure was adapted from a common method used in 
several papers)22,27,29,72,147,212,240,298,299.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The performance of the procedure was tested by spiking triplicate preparations of 
milli-q water with the reference standards at concentration of 50 μg/L and then 
processing through the C18 cartridges. Two volumes (100 and 200 mL) were tested. 
The preconcentration factor was determined as the ratio of volume loaded to volume 
eluted. Blanks (non-spiked milli-q water) processed through SPE were spiked with 
reference standards at 5000 and 10000 μg/L for comparison of recovery to the 
processed milli-q water preparations. The concentrations accounted for 
preconcentration factor of 100 and 200 respectively. Blanks were also processed and 
analysed to determine any possible interferences from the SPE sorbent. The extracts 
were dried using a Thermo Scientific Savant SPD 1010 speed vacuum concentrator 
(Figure 20C). The procedure was used with the HPLC and MEKC methods to the 
analysis of samples taken from the SBRs (Section 3.9). 
 
 
SPE Step Procedure  
Cartridge 
Conditioning 
Cartridges were conditioned using 3 mL 
of methanol, followed by 3 mL of milli-q 
water and 3 mL of milli-q water at pH 2. 
Sample Pretreatment pH of standard and sample solutions was 
adjusted to 2 using concentrated HCl 
Loading 100 and 200 mL of standard and sample 
solutions was loaded at 3 mL/min and 
passed through the cartridges 
Washing and drying The cartridges were rinsed with 3 mL of 
milli-q water and then dried for 10 min on 
the vacuum manifold 
Elution The compounds were then eluted using 1 
mL of methanol 
Eluent drying The eluents were dried using a speed 
vacuum concentrator at room temperature 
for 2.5 hours at level 5.1 vacuum. 
Reconstitution 25uL benzoic acid (final concentration of 
5000 μg/L) and 475 μL of milli-q water 
were added to reconstitute the extracts to 
final volume of 500 µL. The extracts were 
then divided for HPLC and CE analysis. 
B A 
C 
Figure 20. Solid Phase Extraction: (A) SPE equipment used and (B) Speed vac concentrator (C) procedure performed 
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3.3 Configuration and Operation of Sequencing Batch Reactors 
 
3.3.1 SBR set-up 
 Two SBRs, were constructed by adapting materials available in the laboratory, 
with a total height of 35 cm and internal diameter of 6 cm. The working volume of 
763 mL based on the maximum influent height at 27 cm (Figure 21). The height to 
internal diameter ratio was 5.8. Synthetic wastewater (influent) was introduced via 
two tubes at the bottom of the SBRs. Effluent was withdrawn at a height of 13 cm 
from the bottom. Both systems were operated in cycles using an automatic timer 
(Carlo Gavazzi DMB51 multifunction timer) to control the pumps for influent 
addition, aeration and effluent withdrawal. Aeration was performed at the bottom of 
the reactor using a tube connected to a fine bubble aerator, except during influent 
addition, settling and effluent withdrawal. The flow rate for reactor 1 was 194 L/min 
and 90 L/h for reactor 2.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Inoculum for SBR Start-up 
Aerobic granules (10.3 g/L total suspended solids) were generously supplied by 
the Águas de Portugal Nereda municipal wastewater treatment plant in Frielas, 
Lisbon, was used as inoculum (2 g/L, total suspended solids) for start-up of the SBRs. 
The diameter of 20 granules was measured using SteREO Lumar Flourescence 
  
Figure 21. Schematic representation of the two SBRs 
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Stereomicroscope (Carl Zeiss, Göttingen, Germany) with amplification of 13x using 
AxioVision software. 
Determination of Total Suspended Solids  
  The total suspended solids of the granules was measured to determine the 
volume to be placed in each reactor for start-up using a laboratory protocol from the 
Faculdade de Ciêncas e Tecnologia (Mestrado Integrado em Engenharia do 
Ambiente)314. An empty Whatman filter (110 mm, pore size) was weighed and placed 
in a Buchner funnel attached to a filtration apparatus. The granule suspension was 
gently shaken for proper homogenization and 100 mL measured into a beaker. 3 mL 
was removed from the beaker using a pipette with a cut-off tip and evenly applied to 
the empty filter. The filter was washed three times (5 mL distilled water) under 
vacuum, removed using tweezers to a watch glass and dried at 1100C for 1 hr. The 
dried filter was weighed. The value of total suspended solids was calculated as: 
weight of filter +solid (mg) – weight of empty filter (mg)                     Equation 29 
                                         volume added to filter (L) 
 
3.3.2 Operation  
 The reactors were operated for 2 months at room temperature (23 ± 20C) in 
successive cycles of 168 min (2.8 h, 8.6 cycles daily). Reactor 1 was operated in an 
aerobic cycle156 while reactor 2 was operated in the typical anaerobic/aerobic cycle of 
aerobic granular sludge reactors and wastewater treatment plants 156,166,174–182,189–191. 
The phases and respective duration are presented in Table12. An additional contact 
time of 42 min was programmed for reactor 2 to prolong contact of influent with the 
granules due to the short feeding time. In each cycle, 395 mL was withdrawn, which 
accounted for 52% of the reactor volume (calculated using height of the withdrawal 
point of 13 cm).  
Table 12. Phases and duration of reactor operating cycle 
Phases Reactor 1 (aerobic) Reactor 2 (anaerobic/aerobic) 
Time (min) 
Influent feeding (no aeration)   
a. Filling from hallway point 2 2 
b. Additional contact time  42 
Aeration 162 120 
Settling (no aeration) 1 
Effluent withdrawal 3 
Total cycle length 168 168 
 
Hydraulic retention time was calculated as: total cycle length                  Equation 30 
                                                                 volume withdrawn/total working volume 
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The daily influent loading rate was calculated as: 
Influent loading rate = Total volume of influent added daily   Equation 31 
                                      Surface area of clarifier/ cylinder 
 
Dissolved oxygen (mg/L) and pH was monitored by offline instrumentation but 
not controlled (Section 3.6). COD (mgO2/L), phosphorus (mg PO4
3-/L), total nitrogen 
(mg NO3--N/L) and ammonia (mg NH3-N/L) were determined on days 14, 17, 20, 21 
and 27 using the commercial kits. Sludge volume index was determined by measuring 
the time taken to settle to the bottom of the reactor after cessation of aeration. 
3.3.3 Introduction of Ibuprofen and Samples 
The SBRs were dosed with ibuprofen twice, first with 50 µg/L on day 21 of 
operation and with 100 µg/L on day 27. Samples (T0 to T6) were withdrawn 7 times 
from both reactors respectively, during one cycle at times corresponding to t= 0, 30, 
60, 90, 120, 150, 168 min, to determine presence and concentration of ibuprofen the 
metabolites. The first and last samples corresponded respectively to introduction of 
influent and effluent withdrawal. Samples were filtered using sterile syringe filters 
(0.2 µm pore size) to remove biomass and bacteria. Controls were prepared as 
ibuprofen was introduced to the reactors, by spiking synthetic wastewater (Control 
SW) and milli-q water (Control W) respectively in the same dosage. The controls 
were allowed to stand for the length of the same cycle during which sampling was 
performed, to assess if degradation occurred by other mechanisms. Quantification of 
acetate in influent and effluent was performed using the Varian HPLC equipped with 
a UV/Vis detector at wavelength 210 nm, at room temperature and a flow rate of 0.5 
mL/min. The mobile phase was 0.0025M sulphuric acid using a Rezex RFQ-Fast 
Acid H+ (8%) column supplied by Phenomenex (Torrance, CA, USA). 
3.4 High Performance Liquid Chromatography 
3.4.1 Instrumentation 
 
UAlg 
 Preliminary experimentation was performed first using a Varian 380-LC HPLC 
(Varian Inc, Palo Alto, Ca, USA)) equipped with diode array detector (UV/Vis filters) 
controlled by Clarity (Figure 20), followed an Agilent 1220 Infinity series HPLC 
equipped with DAD (lamps with monochromator) operated using Chemstation 
OpenLab Chromatographic Data System (CDS) software (Agilent Technologies, 
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Santa Clara, CA, USA) (Figure 21). The Varian HPLC offered the capacity to use 
isocratic or gradient modes.  Agilent HPLC could only be used in the isocratic mode.  
 Separations were performed at room 
temperature as both instruments were not equipped 
with ovens. An Xbridge® reverse phase C18 column 
(hybrid particle, 250 mm length, 4.6 mm i.d, 5.0 µm 
particle size) attached to a Xbridge C18 guard 
column (20 mm length, 4.6 mm i.d, 5.0 µm particle 
size) (Waters Corporation, Milford MA, USA). The 
injection volume was 20 µL and performed 
manually. A wavelength scan was performed on the 
Varian HPLC at 220, 221, 223 and 225 nm, to 
determine the wavelength at which ibuprofen 
showed the highest absorbance. Subsequent 
experiments were subsequently performed at the 
selected wavelength (221 nm).  
 
USP 
Method development and analysis 
of samples were performed using a 
Shimadzu Prominence-i LC-2030 HPLC 
system coupled to UV/Vis DAD 
(deuterium lamp with monochromator) 
controlled by Lab Solutions Analysis 
Data Software (Shimadzu Corporation, 
Kyoto, Japan) (Figure 22), capable of operation in gradient and isocratic modes.  
Chromatographic separations were performed using a Shimpack C18 reverse phase 
column (VP-ODS, 250 mm length, 4.6 mm i.d, 4.6 µm particle size) (Shimadzu 
Corporation, Kyoto, Japan). A Shimadzu Shimpack guard column (GVP-ODS, 10 
mm length, 4.6 mm i.d., 5 µm particle size) was attached. The injection volume was 
20 µL and was performed using an auto-injection module. 
 
 
 
 Figure 23. Shimadzu Prominence-i LC-2030 HPLC 
B 
A 
Figure 22. A) Varian 380-LC HPLC (B) 
Agilent 1220 Infinity Series HPLC 
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3.4.2 Method Development and Optimization 
 
3.4.2.1 UAlg: Method Development 
 Method development was initiated at UAlg. Several mobile phases in literature 
used solvent A as water adjusted to pH 3 or ammonium acetate buffer and solvent B 
as methanol or acetonitrile to successfully separate and analyse ibuprofen and the 
metabolites86,147,223. The tested mobile phases are listed in Table 13. Preliminary 
assessments were performed to determine retention time and retention factor (k) of 
each compound, resolution between the four compounds and smallest concentration 
detectable, identification of critical peak pair. Experimental design described in 
Section 3.7.1, was used to optimize retention factor (1<k<10 or 0.5< k <20) and 
resolution (≥1.5) of the four compounds once a mobile phase was identified. 
Table 13. Mobile phases tested during method development at UAlg 
Mobile Phase Composition Chromatographic 
mode 
Test flow 
rate 
(mL/min) 
Reference 
Solvent A Solvent B     
Water with 0.1% 
glacial acetic acid 
Methanol 65:35, (v/v) Isocratic223 0.8  
Water, pH 3 
adjusted using 
glacial acetic acid 
Acetonitrile 50:50 (v/v) Isocratic 2 86 
Water Methanol 60:40, (v/v) Isocratic 0.8 147 
10 mM ammonium 
acetate, pH 4 
Methanol 
(1) Acetonitrile 
 
 Isocratic 1 142 
10 mM ammonium 
acetate, pH 4.5 
Acetonitrile 
 
60:40, (v/v) 
65:35, (v/v) 
70:30, (v/v) 
Isocratic 1  
10 mM ammonium 
acetate, pH 5 
Acetonitrile 
 
60:40, (v/v) 
65:35, (v/v) 
70:30, (v/v) 
Isocratic 1  
25 mM ammonium 
acetate, pH 4 
(1) Methanol 
(2) Acetonitrile 
 
 Isocratic 0.8 
1 
142 
 
25 mM ammonium 
acetate, pH 4.5 
Acetonitrile  Isocratic 1 
25 mM ammonium 
acetate, pH 5 
Acetonitrile  Isocratic 1 
1Varian 380-LC HPLC     2Agilent 1220 HPLC 
 
3.4.2.2 USP: Method Development and Optimization 
 Method development was continued and finalized at USP using a Shimadzu 
Prominence-I LC 2030 HPLC. Preliminary assessments of the retention time and 
retention factor of each compound, resolution between the peaks and verification of 
the critical peak pair were carried for each mobile phase listed in Table 14 by 
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performing a gradient separation from 5 - 100% B in 15 min using a flow rate of 2 
mL/min at a temperature of 30 0C, at 221 nm. Retention time for each compound was 
confirmed by injecting solutions of individual compound. The initial chromatograms 
were evaluated to determine if isocratic separation was possible. The mobile phase 
with the best results on evaluated criteria (water (solvent A) and acetonitrile (solvent 
B) both acidified with formic acid, 0.01% (v/v)) was selected for further 
experimentation to optimize the gradient separation focusing on retention factor 
(1<k*<10), resolution between the compounds, particularly for the critical peak pair 
(≥1.5), peak efficiency and signal to noise ratio of the four compounds, at two 
temperatures (250C and 300C). Signal to noise ratio was evaluated at two wavelengths 
(221 and 230 nm) and the wavelength with the higher ratio was selected for 
experimental analysis. 
 
Table 14. Mobile phases tested during method development at USP 
Mobile Phase Composition Chromatographic 
mode 
Test flow 
rate 
(mL/min) 
Reference 
Solvent A Solvent B     
Water Acetonitrile Both acidified with 
0.01% formic acid (v/v) 
Gradient 2 30 
Water Acetonitrile Both acidified with 
acetic acid, 3% (v/v) 
Gradient 2  
Water Acetonitrile Both acidified with 
acetic acid, 1% (v/v) 
Gradient 2  
Water Acetonitrile Both acidified with 
formic acid, 0.1% (v/v) 
Gradient 2  
Water, pH 3 (1) Methanol 
(2) Acetonitrile 
adjusted to pH 3 with 
glacial acetic acid 
Gradient 2 86 
Water, pH 3 Acetonitrile Adjusted to pH 3 with 
phosphoric acid 
   
 
3.4.2.3 Preparation of Mobile Phases 
 The buffers for the mobile phases were prepared on a weight basis using 
volumetric flasks and diluting to volume with milli-q water. The solvents acidified 
with formic acid and acetic acid were prepared on a volume by volume basis by 
adding the appropriate volume to volumetric flasks and diluting to volume with water 
or acetonitrile respectively. The pH of the ammonium acetate buffers and water, pH 3 
was adjusted using glacial acetic acid. All solvents were vacuum filtered using 0.22 
µm polypropylene membrane filters to remove impurities and then sonicated for 10 
min to remove excess gas that could interfere with the system. 
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3.4.3 Identification and Quantification of Ibuprofen and Metabolites 
 Sample analysis was carried out on the Shimadzu HPLC System using the 
method optimized after development work. The details of the optimized method and 
gradient programme are given in Tables 15 and 16. 
Table 15. Optimized chromatographic conditions for separation of Ibuprofen and metabolites 
Chromatographic parameter Optimized condition 
Mobile phase Solvent A: water acidified with formic acid, 0.01% (v/v)  
Solvent B: acetonitrile acidified with formic acid, 0.01% (v/v) 
Flow rate (mL/min) 2 mL/min 
Temperature (0C) 30 
Injection volume (µL) 20 
Wavelength (nm) 230 
 
Table 16. Optimized gradient programme for separation of Ibuprofen and metabolites 
Time (min) % Solvent B 
0 25 
12 80 
12.5 25 
16 25 
 
3.5 Capillary Electrophoresis 
3.5.1 Instrumentation 
 
Method development and 
analysis of samples was performed 
using a Beckman Coulter ProteomeLab 
PA800 capillary electrophoresis system 
coupled to a DAD detector (UV/Vis 
filters) controlled by 32 KaratTM 8.0 
software. (Figure 24) 
Chromatographic separations were performed using an unfused and uncoated silica 
capillary (75 µm i.d) (Polymicro Technologies, Phoenix, AZ, USA) at wavelength of 
214 nm and room temperature. Standard and sample solutions were injected 
hydrodynamically for 3 s towards the cathode. Preliminary assessment was performed 
using a capillary of total length 50.5 cm, length to detector of 40 cm and applied 
voltage of 25 kV. To reduce the migration time, the total length of the capillary was 
decreased to 40 cm and the length to the detector to 29.5 cm, subsequent experiments, 
method development and sample analysis were performed with these dimensions.  
 
 
 Figure 24. Beckman Coulter ProteomeLab 
PA800 CE System 
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3.5.2 Method Development and Optimization 
 
 Preliminary assessment was performed using 10 mM borate (pH 9) as BGE to 
determine compound migration time and effective mobilities and the critical peak 
pair. Effective mobility curves were plotted as a function of pH and a response 
function used to identify the best pH for separation. Peak resolution and migration 
time of the compounds were examined in two different background electrolytes, 
acetate buffer at pH 5 (compounds in neutral form) and borate buffer at pH 9 
(compounds in anionic form). Four factors critical to CE separation: buffer 
concentrations (10, 20, 25, 30 and 50 mM), addition of micelles (SDS, cetrimonium 
bromide), organic solvent (acetonitrile, methanol, tetrahydrofuran) and separation 
voltage (20, 22, 24, 25 kV), were examined to determine their influence on migration 
time, critical resolution and peak efficiency (Table 17). Polarity of hydrodynamic 
injection mode (normal and reverse) was also assessed.  
         
Table 17. BGE and conditions examined for CE method development 
Electrolyte Buffer 
concentration 
(mM) 
Micelle Micelle 
concentration 
(mM) 
Organic Solvent Organic 
Solvent 
concentration 
(%) 
Separation 
voltage 
(kV) 
Acetate 
buffer, pH 5 
20, 25, 30, 
50 
- - - - 20, 22, 24, 
25 
Borate buffer, 
pH 9 
10, 15, 20, 
25, 30 
SDS 
CTAB 
20, 30, 40 
0.2 
Acetonitrile 
Methanol 
Tetrahydrofuran 
10, 20 
10 
5, 10, 15, 20 
20, 25 
 
A wavelength scan (200, 214, 254 and 280 nm) was performed after selection of best 
electrolyte for separation to determine the wavelength of highest absorbance of the 
compounds and signal to noise ratio. This wavelength was subsequently used for 
further work. Experimental design described in Section 3.7.2 was used to optimize 
and resolution (≥1.5) of the four compounds once a BGE was identified. 
3.5.3 Stacking 
  After selection of the electrolyte, most suited for separation of the compounds, 
experiments were performed to investigate enhancement via on-line preconcentration 
using field amplified sample stacking. The conditions examined for optimization of 
peak height were placement of the milli-q water plug (before and after sample), length 
of injection of water plug (t=0, 2, 3, 5, 7, 10, 12, 16, 18, 20, 30s), length of injection 
time for the sample (t= 3s, 6s), addition of organic solvent to the water plug in the 
same ratio as the electrolyte.  
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3.5.4 Background Electrolyte Preparation 
Acetate Buffer, pH 5 
 The buffer was prepared on a weight basis by weighing the appropriate amount 
of glacial acetic acid to obtain the desired final concentration in a volumetric flask. 
The pH was adjusted using 0.5M sodium hydroxide.  
 
Borate Buffer, pH 9 
The buffer was prepared on a weight basis by weighing the appropriate amount 
of sodium tetraborate decahydrate and additive and by adding the appropriate volume 
of organic solvent in a volumetric flask to obtain the desired final concentration, then 
filtered. The pH of borate solutions did not require adjustment. 
3.5.5 Identification and Quantification of Ibuprofen and Metabolites 
 
  The samples were analysed using the MEKC method developed and optimized 
for the separation of the compounds. The details are given in Table 18. 
Table 18. Optimized MEKC conditions for separation of Ibuprofen and metabolites 
MEKC parameter Optimized condition 
BGE composition 
Borate concentration (mM) 
SDS concentration (mM) 
% THF 
 
15 
40 mM  
15  
  
Runtime (min) 15 min 
Separation voltage (kV) 20  
Temperature (0C) 25 
Injection mode Hydrodynamic 
On-line preconcentration Water plug containing 15% THF injected 
after sample 
Water injection (time, pressure) 16 s, 0.5psi 
Sample injection (time, pressure 3 s, 0.5 psi 
Wavelength (nm) 200 
Capillary dimensions  
Total length (cm) 40 
Length to detector (cm) 29.2 
 
3.6 Supporting Instruments, Equipment, Materials 
  Supporting instruments and equipment for experimental procedures for weighing, 
preparation of solutions, measurement and adjustment of pH, sonication of mobile 
phases are shown below in Table 19. 
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Table 19. Supporting instruments and equipment 
Instrument Model Manufacturer Capacity Use 
Balance1 ECN611-2271 VWR, Carnaxide, 
Portugal 
310 g Weighing of 
reagents 
Balance1 440-35N Kern & Sohn, 
GmbH, Germany 
400 g Weighing of 
reagents 
Balance, 
analytical2 
AB204-S Mettler Toledo, 
Columbus, OH, 
USA 
210 g Weighing of 
reagents 
Balance, semi-
micro2 
AUW 220D Shimadzu, Kyoto, 
Japan 
220 g Weighing of 
reagents 
Multi water 
analyzer: 
dissolved 
oxygen  
CD650 Eutech 
instruments, 
Landsmeer, 
Netherlands 
600% DO 
saturation 
90.00 mg/L 
DO 
concentration 
DO monitoring of 
SBR 
Graduated 
pipettes 
 Pyrex, NY, USA 1 mL, 2 mL, 
5 mL, 10 mL 
Preparation of 
standard solutions 
pH meter1 GLP 21 Crison 
Instruments, 
Barcelona, Spain 
 Adjustment of 
solution pH, pH 
monitoring of 
SBR 
pH meter2 DM-20 Digimed, São 
Paulo, Brazil 
-2-20 Adjustment of 
solution pH 
Membrane 
filters1  
hydrophilic 
polypropylene,  
Pall Life 
Sciences, MI, 
USA 
0.2 µm Filtration of 
solutions 
Micropipette  Eppendorf, NY, 
USA 
1-10 µL, 20-
200 µL, 10-
1000 µL 
Preparation of 
standard solutions 
and reagent 
solutions 
Oven1 ED53 Binder, Germany Max 3000C Drying filter  
Syringe 
membrane filter1 
Polyethersulfone 
membrane 
VWR, Carnaxide, 
Portugal 
0.2 µm Filtration of 
solutions 
Syringe filter2 Captiva, 
Polytetrafluoroethylene 
Agilent 
Technologies, 
CA, USA 
0.2 µm Filtration of 
solutions 
Ultrasonic bath1,2 2510E-DTH Branson, CT, 
USA 
2.8 L Sonication of 
mobile phase 
 
Volumetric 
flasks1,2 
Pyrex 
Normax 
Labbox 
5, 10, 20, 25, 50, 
1000 mL 
 Preparation of 
standard solutions 
and reagent 
solutions 
Whatman filter 
paper12 
Silicone treated filter 
paper 
Whatman, plc, 
GE Healthcare 
Services, 
Buckinghamshire, 
UK 
110 nn, pore 
size 
Filtration of 
solutions 
TSS 
1UAlg  2USP 
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3.7 Experimental Design 
 
3.7.1 HPLC: Optimization of Critical Resolution 
UAlg 
 A full factorial design of 22 was employed to evaluate the factors critical to the 
separation of the critical peak pair (2OH and CBX) and their interaction. The factors 
considered were %solvent B (methanol) and mobile phase pH at two levels (-1, +1). 
The experiments were performed in mobile phase of 10 mM ammonium acetate 
buffer (solvent A) and methanol (solvent B). The mobile phase, factors and values, 
listed in Table 20, were selected after exploratory runs to determine the conditions 
with best potential for separation of the critical peak pair and analysis time.  
Table 20. Selected factor affecting resolution of critical pair and levels 
Level Factor 
pH % Solvent B 
High (+1) 4.5 40 
Low (-1) 4.0 35 
 
The factorial design, which consists of four experiments is given in Table 21.  
 
Table 21. Full factorial Design 22 employed for investigating resolution of critical peak pair 
Experiment 
No. 
Factor 
pH % Solvent B 
1 -1 -1 
2 1 -1 
3 -1 +1 
4 +1 +1 
 
The resulting chromatograms was ranked with the response functions CRS, CRF, 
CEF, Rsum, Rcp and RP to determine the most optimum conditions for separation.  
3.7.2 MEKC: Optimization of Critical Resolution and Migration time  
 
  A full factorial design of 23 was employed to optimize the MEKC method, 
evaluating the factors critical to the separation of the critical peak pair (2OH and 
1OH), compound migration time and their interaction (response variables). The factors 
considered were borate concentration, SDS concentration and %THF at two levels (-1, 
+1). The experiments were performed for the borate buffer. The electrolyte 
composition, factors and their values, listed in Table 22, were selected after 
exploratory runs to determine the conditions with best potential for separation of the 
critical peak pair. The factorial design, which consists of 8 experiments is given in 
Table 23.  
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Table 22. Selected factor affecting resolution of critical pair and levels 
Level Factor 
Borate concentration  
(mM) 
SDS concentration 
(mM) 
%THF 
High (+1) 20 40 15 
Low (-1) 15 20 10 
 
Table 23. Full factorial Design 23 employed for investigating resolution of critical peak pair 
Experiment 
No. 
Factor 
Borate concentration  
(mM) 
SDS concentration 
(mM) 
%THF 
1 -1 -1 -1 
2 +1 -1 -1 
3 -1 +1 -1 
4 +1 +1 -1 
5 -1 -1 +1 
6 +1 -1 +1 
7 -1 +1 +1 
8 +1 +1 +1 
 
The resulting electropherograms was ranked with the response functions CRS, CRF, 
CEF, Rsum, Rcp and RP to determine the most optimum conditions for separation. 
3.8 Method Validation 
 The validation of both methods were conducted in solvent (milli-q water) 
according to the ICH Guideline Q2 (R1)304,310 and AOAC Guidelines for Standard 
Method Perfomance Requirements308.  
 Specificity was established through identification of the separation conditions 
best suited to achieve resolution ≥ 1.5 and injection of individual reference standards 
to confirm migration and retention time for each compound. Linearity was assessed 
using six standard solutions ranging from 15-125 µg/L prepared in solvent (water). 
The range was chosen to analyse the concentrations dosed to the SBRs (50 and 100 
µg/L). Replicate injections of each concentration was performed (5 injections were 
used in HPLC, 6 injections were used for CE). The Hartley’s Fmax test (significance 
level α 0.05) was applied to determine any statistically significant difference in the 
variances of the standard solution series. Calibration curves were constructed using 
linear regression analysis. Residual plots were prepared to confirm linearity. 
Calibration curves were also prepared in sample matrix (synthetic wastewater). 
Student’s t-test was applied to compare the y-intercepts of the solvent and matrix 
calibration curves to assess matrix effect and any statistically significant difference 
between the two curves. If there was statistically significant difference, the remaining 
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the remaining validation parameters and sample analysis would be performed using 
the matrix calibration curve. 
 LOD was determined from a calibration curve prepared from the replicate 
measurements of the three lowest concentrations (15, 25 and 50 µg/L). LOD was 
calculated as the mean of the LODs determined from the residual standard deviation 
and slope of the solvent calibration curve. The accuracy of LOD was assessed by two 
conditions (LOD < 15 µg/L, condition 1; 10 x LOD > 15µg/L, condition 2). LOQ was 
obtained from LOD. Range was determined using LOQ and the highest standard 
concentration.  
 Precision was assessed through repeatability (intra-day) and intermediate 
precision (extra-day). Repeatability was calculated by fifteen independent analyses of 
three sample solutions for HPLC and eighteen analyses for CE. Synthetic wastewater 
was at three concentrations 25, 50 and 100 μg/L respectively. The Dixon’s Q-test 
(significance level α 0.05) was applied to check for outliers in the results. The 
Hartley’s Fmax test (significance level α 0.05) was then applied to evaluate statistical 
significant difference between the variances of the results. Intermediate precision was 
obtained by repeating injections on a second day. 
 Recoveries were evaluated by comparison of concentrations obtained after SPE 
with initial fortification in synthetic wastewater for three concentrations 25, 50 and 
100 µg/L. Blank (non-spiked samples) were analysed and amounts found were 
subtracted from those of the spiked samples. Analyte quantification for linearity and 
recovery was performed using internal standard (benzoic acid). Robustness was 
studied during method development and optimization for the effect on peak resolution 
by varying HPLC (flow rate, temperature, mobile phase, detection wavelength) and 
MEKC experimental conditions (borate and SDS concentration, separation voltage, % 
THF), particularly for the critical peak pair. 
3.9 Application of HPLC and MEKC Methods to SBR Samples 
Both methods were applied for the analysis of synthetic wastewater SBR 
samples, synthetic wastewater and milli-q water controls. Off-line SPE was used for 
both methods as described in Section 3.3.3, to preconcentrate analyte concentrations 
to method sensitivity limits. 200 mL of sample and calibration curve standard 
solutions were processed using the Strata C18e cartridges. Analyte concentration was 
assessed using solvent calibration curves. 
66 
4. Results and Discussion 
4.1 Overview of Thesis Experimental Plan and Work 
Águas do Algarve seeks to improve local urban wastewater treatment by 
installing an aerobic granule WWTP. The company is interested in the treatment’s 
capacity to degrade priority emerging environmental pollutants frequently detected in 
WWTPs such as pharmaceuticals. The granules show resistance and adaptability to 
toxic compounds and operating cycles are malleable to produce desired effluent 
conditions (Section 1.6). The NSAID, ibuprofen is a good choice for study due to its 
global popularity and persistence in conventional WWTP influent and effluent, 
surface and ground waters, along with its metabolites (1-hydroxyibuprofen, 2-
hydroxyibuprofen and carboxyibuprofen), despite high removal efficiency by aerobic 
biodegradation (Section 1.4 and 1.5).  
Two aerobic granule SBRs were constructed and operated using synthetic 
wastewater at laboratory scale in anaerobic/aerobic and aerobic cycles respectively 
(Section 3.3.1- 3.3.2). The SBRs were dosed with ibuprofen at environmentally 
realistic concentrations of 50 (day 21) and 100 μg/L (day 27) to investigate their 
efficiency and type of operating conditions on the degradation of ibuprofen and its 
metabolites. Synthetic wastewater and milli-q water controls were prepared at the 
same time as ibuprofen introduction and in the same dosage, but not passed through 
the SBRs. Samples were taken from each reactor at several timepoints for analysis 
with the controls (Section 3.3.3). SBR performance was monitored by several 
parameters. 
HPLC (Section 2.2) and CE (Section 2.3), coupled with UV/Vis, were chosen 
to develop analytical methods for the compounds of study. Several chromatographic 
and CE methods have been developed for successful environmental analysis of 
ibuprofen with other pharmaceuticals but few include the metabolites (Section 2.1). 
HPLC development and optimization were initiated at UAlg and completed along 
with validation at USP (Section 3.4, 3.7, 3.8). CE development, optimization and 
validation was performed at USP (Section 3.5, 3.7, 3.8). Off-line SPE was used to 
preconcentrate analyte concentrations to method detection limits (Section 3.2). On-
line preconcentration was additionally used for CE (Section 3.5.3). After method 
validation was performed, both methods were applied to analyse the SBR samples 
(Section 3.9). The results are discussed in the following sections. 
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4.2 SPE 
An SPE procedure successfully used in previous literature was selected for use 
in this study22,27,29,72,147,212,240,298,299. The performance of the procedure was evaluated 
using Strata C18e cartridges as described in Section 3.2. Milli-q water, spiked with 
reference standards at 50 μg/L with pH adjusted to 2 using concentrated HCl were 
processed. Two volumes (100 and 200 mL) were studied. Analytes were eluted using 
methanol. To allow compatibility of the same SPE extract for both HPLC and MEKC 
analysis, eluents were dried and reconstituted in milli-q water (solvent). Recoveries 
were compared for SPE sorbent matrix effect to blank (milli-q water) spiked post SPE 
with reference standards at 5000 and 10000 μg/L respectively (accounting for 
preconcentration factor of 100 and 200). The extracts were analysed by HPLC using 
an internal standard calibration curve (2000 – 14000 μg/L, Table 10). The recoveries 
are displayed in Table 24. 
Table 24. Mean SPE recoveries in milli-q water, 95% confidence interval, Strata C18e cartridges (n=3)  
Compound 100 mL 200 mL 
Mean % recovery  RSD 
% 
Mean % 
recovery 
RSD 
% 
2OH 147 ± 8.1 4.9 154 ± 46 26 
CBX 161 ± 13 6.7 152 ± 11 6.5 
1OH 165 ± 7.3 3.9 155 ± 9.8 5.6 
IBU 66 ± 32 43 88 ± 49 49 
 
The recoveries for 2OH, 1OH and CBX were significantly higher while IBU 
recovery was lower than the AOAC recommended 110%308. These results were 
unexpected as previous studies that applied this sorbent to ibuprofen, obtained 
recoveries no larger than 103%72,299. These recoveries could be due to matrix effect 
from the SPE sorbent, highlighted by comparison of the recoveries of the blanks 
spiked post matrix at 5,000 and 10,000 μg/L, also calculated using the calibration 
curve, that are closer to the AOAC limit (Table 25). Volumetric errors from the 
micropipettes used to prepare the solution, could account for the values over 110%. 
Blank matrix processed through the SPE was analysed, however no peaks indicating 
possible interferences were observed that could account for the high recoveries.  
Table 25. Recoveries calculated from calibration curve for blank matrix spiked post SPE 
Compound % recovery obtained for 5,000 μg/L  
Preconcentration factor of 100 
% recovery obtained for 10,000 μg/L 
Preconcentration factor of 200 
2OH 103 112 
CBX 111 112 
1OH 103 112 
IBU 115 119 
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Due to limited numbers of SPE cartridges and the inability of the supplier to 
provide more C18 cartridges or the polymer sorbents for several months, investigation 
of these results or comparison of recoveries obtained from other SPE sorbents could 
not be performed. The SPE procedure was still used for method validation and sample 
analysis as the reactors were dosed at environmentally realistic concentrations (50 
μg/L), which required preconcentration to analyse at method detection levels.  The 
volume of 200 mL was chosen for the higher preconcentration factor (Annex 2). 
4.3 HPLC 
4.3.1 Method Development and Optimization 
UAlg 
Method development was initiated at UAlg. Conditions were selected after 
assessing compound physico-chemical properties and expected behaviour under 
experiment conditions and literature review 27,86,142,147,223(Table 1). The Agilent 1220 
HPLC (isocratic elution) was used for most experiments. This HPLC had greater 
sensitivity for analyte detection in the environmentally realistic concentrations dosed 
to the SBRs, as its UV/Vis detector used a monochromator to provide the UV 
wavelength in contrast to the UV/Vis filters of the Varian HPLC detector. Reference 
standard solutions prepared in solvent (milli-q water) were used to perform the 
experiments (Table 8).  
Mobile phases (Table 13) were tested to determine reproducibility of 
compound separation. Preliminary experiments ascertained influential factors and 
their levels for experimental design. Peaks were not visible in the mobile phases that 
employed water or acidified water as solvent A and methanol as solvent B. The 
compounds are in neutral form and hydrophobic, therefore they would be retained 
very strongly to the stationary phase, resulting in an extremely long retention time 
particularly in methanol257. Peaks were finally observed using water adjusted to pH 3 
with acetic acid (solvent A) and acetonitrile (solvent B), 50:50 (v/v). The compounds 
are neutral in this pH. A wavelength scan (220, 221, 223 and 225 nm) confirmed the 
highest absorbance was observed at 221 nm in keeping with published 
literature148,223,225. 2OH and CBX were identified as the critical peak pair. Varying 
pH, type of organic solvent and % solvent B that would most influence the selectivity 
of the compounds could not produce separation of 2OH and CBX using water, pH 3 
as solvent A. Methanol increased the selectivity of the compounds to the column 
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stationary phase and increased retention time, particularly for ibuprofen, which as the 
most hydrophobic of the compounds257. Acetonitrile decreased both retention and 
runtimes without changing selectivity (some chromatograms are provided in Annex 
3). Solvent A was therefore switched to ammonium acetate buffer to change 
selectivity based on the ionic nature of the analytes. 
Buffer concentration (10 and 25 mM), buffer pH (4, 4.5, 5), solvent B 
(methanol, acetonitrile) and % solvent B (30, 35, 40%) were evaluated. Increasing 
buffer concentration above 10 mM increased retention time particularly for ibuprofen, 
without influencing critical resolution. pH 5, which ionized the analytes, caused peak 
distortions regardless of organic solvent and percentage used. 2OH and CBX coeluted 
in acetonitrile regardless of buffer concentration, pH and % solvent B. Methanol in 
contrast gave selectivity that produce critical pair separation but gave long runtimes. 
The conditions that gave the best potential for critical pair separation were identified 
as 10 mM buffer, pH 4 and 4.5 with methanol (solvent B, 35, 40%). Flowrates higher 
than 1 mL/min resulted in system pressure exceeding recommended limits due to 
mobile phase viscosity with methanol257.  
Full factorial 
design (Section 3.7.1). 
showed the best 
separation was obtained 
in 10 mM ammonium 
acetate buffer pH 4.5: 
methanol (65:35 v/v), as 
displayed in Figure 25. 
This was confirmed by 
the calculated response 
functions (Annex 3). 
Attempts were made to 
prepare a calibration curve in the working range of 50 – 500 μg/L in preparation for 
evaluating performance of the SPE procedure. However, the reproducibility of 
replicate injections and injection volume was poor due to a problem with the HPLC 
injector. Linearity could not be established before the end of thesis work at UAlg, 
therefore method development was transferred when the thesis period shifted to USP. 
 
Figure 25. UAlg HPLC optimized conditions: 10 mM ammonium acetate 
buffer pH 4.5: methanol (65:35 v/v) 
Peaks 1: CBX, 2: 2OH, 3: 1OH, 4: IBU 
1 
2 
3 
4 
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USP 
The separation conditions developed at UAlg could not be reproduced at USP, 
possibly due to differences in the HPLC columns used. Both stationary phases were 
C18, however the manufacturers were different and the UAlg column was a 
chemically modified hybrid. The order of peak elution as different with CBX to elute 
first on UAlg column and 2OH eluting first on the USP column. 
Exploratory linear gradients were performed using water acidified with formic 
acid, acetic acid and phosphoric acid respectively (solvent A) and methanol and 
acetonitrile (solvent B) as solvent A (Table 14). Water and acetonitrile, both acidified 
to pH 3 with phosphoric acid, produced broad peak shapes and compounds were 
difficult to identify from the baseline. The compound peaks were not visible in the 
chromatograms obtained with 3% acetic acid, 1% formic acid and water pH 3 as 
solvent A.  A significant negative baseline drift was observed with acidified solvent 
A. This phenomenon occurs when solvent B absorbs at a lower wavelength than 
solvent A and can create problems in chromatographic integration. Solvent B was 
therefore acidified in the same proportion as solvent A for subsequent experiments to 
correct this problem. The positive baseline drift is observed as solvent B has stronger 
absorbance then solvent A. However this does not affect chromatographic quality255.  
Peak detection and 
compound separation was 
achieved with water 
(solvent A) and acetonitrile 
(solvent B), both acidified 
with 0.01% formic acid as 
shown in Figure 26 with the 
order of elution. Selectivity 
is based on individual 
compound hydrophobicity. 
At gradient start, low % B 
causes stronger mobile phase polarity. Hydrophobic compounds are therefore strongly 
attracted through hydrophobic interactions due to bonds formed with hydrophobic 
hydrocarbons of the C18 stationary phase, increasing retention time. The strength of 
this interaction varies according to individual molecular structure256,257. The retention 
times for each compound was confirmed. k* was 2.6 (equation 4). Compound 
Figure 26. Exploratory gradient for compound separation in water and 
acetonitrile, both with 0.01% formic acid, v/v 
Peaks 1: 2OH, 2: CBX, 3: 1OH, 4: IBU 
1 
4 
3 
2 
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separation by isocratic elution was possible (Section 2.2.1, equation 1) as ∆tr/ tG value 
was intermediate (0.30). Isocratic elution was tested at 53% B (equation 2), but 2OH 
and CBX coeluted. Experiments were therefore continued in this mobile phase with 
gradient elution.  The compounds are neutral in this acidic mobile phase. 
Optimization of Separation Conditions 
Gradient separation conditions and range were optimized by increasing starting 
%B and reducing final %B while maintaining resolution ≥ 1.5. The best temperature 
and detection wavelength were determined to 300C and 230 nm according to 
resolution and signal to noise ratio. The optimized conditions, displayed in Figure 27, 
were linear gradient 25-80% in 16 min at 300C, flow rate of 2 mL/min with k* of 4.9.  
 
 
 
 
 
 
 
 
 
Figure 28 shows the final optimized conditions with confirmation of the suitability of 
benzoic acid as internal standard as it did not coelute with the target analytes. Table 
26 shows the chromatographic quality parameter results. Analysis in synthetic 
wastewater showed no interferences with compound elution and similar retention 
times and resolution were observed (Annex 3). 
 
 
 
 
 
 
 
 
 
Figure 27. Optimized HPLC gradient conditions 
water (solvent A), acetonitrile (solvent B), both acidified with 0.01% formic acid;  
Peaks 1: 2OH, 2: CBX, 3: 1OH, 4: IBU 
1 
2 
3 
4 
Figure 28. HPLC: Verification of benzoic acid suitability as internal standard 
water (solvent A), acetonitrile (solvent B), both acidified with 0.01% formic acid; Peaks 1: BA, 2: 2OH, 3: 
CBX, 4: 1OH, 5: IBU 
1 
2 3 
4 
5 
72 
Table 26. Chromatographic quality parameters for optimized HPLC method 
Compound Retention time Rs Column Efficiency* Tailing Factor 
Benzoic acid 4.848  18419 1.1 
2OH 5.248 2.8 23146 1.1 
CBX 5.515 2.0 25505 1.0 
1OH 6.382 6.1 30722 1.0 
IBU 11.138 31.1 76849 1.0 
*N ≥17500 is recommended for 25 cm column257 
4.3.2 Validation 
 
Validation was performed in solvent (milli-q water) as described in Section 3.8. 
The results are shown in Table 27. 
Table 27. Validation results for HPLC method in milli-q water  
Compound Linear equation r2 r LOD  
μg/L 
LOQ 
μg/L 
Range 
μg/L 
Precision 
 Repeatability 
%CV 
Intermediate 
Precision 
1OH y=0.0341x -0.0017 0.9766 0.9882 3.2 9.5 9.5 - 125 1.0 0.05 
2OH y=0.041x-0.0032 0.9795 0.9897 3.8 11 11 - 125 9.4 0.04 
CBX y=0.0347x-0.0018 0.9803 0.9901 4.3 13 13 - 125 1.6 0.04 
IBU y=0.0234x-0.0052 0.7477 0.8647 7.5 23 23 - 125 2.5 0.04 
 
The individual compound retention times and peak resolution confirmed 
specificity. Linearity was assessed for a working range of 15 –125 μg/L, based on the 
concentrations dosed to the SBR (50 and 100 μg/L). Two calibration curves were 
prepared in solvent (milli-q water) and matrix (synthetic wastewater) respectively 
(Table 11). SPE used to provide a preconcentration factor of 200 bringing detection to 
the range of 3000 – 25,000 μg/L. The variances of the standard solution series were 
evaluated for statistically significant difference using Hartley’s-Fmax test as described 
in Section 2.10.2. 2OH, CBX and IBU passed, however 1OH did not (Fmax values are 
shown in Annex 1b).  
The calibration charts were 
nevertheless plotted. The linear 
equation and regression parameters 
for each compound are shown in 
Table 27. The 2OH curve is shown 
in Figure 29 and the remaining 
curves are given in Annex 4a. 
Residual plots were prepared to 
confirm linearity, particularly for 
IBU (Annex 4b). The plots for all compounds plots show random distribution for the 
first four standard concentrations indicating good linearity, however there is a sharp 
y = 0.0401x - 0.0032
R² = 0.9795
0
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Figure 29. HPLC calibration curve for 2OH in water 
73 
increase in standard deviation from concentration 4 to concentration 5 (100 μg/L), 
followed by a decrease to concentration 6 (125μg/L). This could be due to matrix 
effect from the SPE sorbent or volumetric errors during sample preparation292. 
LOD was determined using the residual standard deviation and deviation of the 
y-intercept obtained from a calibration curve of the three lowest concentrations. The 
value which is the ratio of compound concentration to concentration of BA, was 
converted to concentration by multiplying with BA concentration (5000 μg/L) and 
then dividing by the preconcentration factor of 200. The LODs passed the acceptance 
tests for correct calculation (Annex 4c). LOQ was calculated from LOD, however the 
IBU LOQ is higher than the minimum calibration concentration. The range was 
determined from LOQ to the maximum calibration standard used.  
Repeatability was assessed using solutions of 25, 50 and 100 μg/L. Outliers 
were evaluated using the Dixon’s Q-test (Values given in Annex 1c). 2OH was the 
only compound that did not pass. The variances of the standard solution series were 
evaluated for statistical significant difference using the Hartley’s Fmax test. IBU and 
2OH failed the test (Annex 1b). determined from LOQ to the maximum calibration 
standard used.  Repeatability still calculated as the average %CV, although some of 
the compounds failed the statistical tests. Repeatability is acceptable for all 
compounds according to AOAC recommendations (<21 % for 10 ppb, <15% 100 
ppb)308. The solutions were injected on a second day for intermediate precision, which 
was calculated as SD of all 30 measurements.  
 Method recovery, shown in Table 28, was determined by calculating the 
concentrations obtained in three spiked solutions processed through SPE (25, 50 and 
100 μg/L) from the calibration curve. 2OH is the only compound with overall 
recoveries close to AOAC recommendations (60 - 115% for 10 ppb, 80-110% for 100 
ppb)308. 1OH and CBX had good recoveries for 50 and 100 μg/L and high for 25 
μg/L. IBU had good recoveries for 50 μg/L and high recoveries for 25 and 100 μg/L. 
This indicates possible matrix effects from the sorbent or sample preparation. 
Table 28. HPLC: Recoveries obtained for the compounds, n=1 
Concentration, μg/L 25 50  100 
Compound % Recovery 
2OH 75 94 99 
1OH 124 103 105 
IBU 130 110 127 
CBX 122 106 102 
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Comparison of the Solvent and Matrix Matched Calibration Curves 
  Statistically significant variance in the synthetic wastewater standard solution 
series was assessed using the Hartley’s Fmax test. Only 1OH passed the test (Annex 1). 
The calibration charts were nevertheless plotted for each compound. 2OH is shown in 
Figure 30. The curves for the remaining compounds are given in Annex 4a. The 
regression parameters are given in Table 29. Residual plots were prepared to confirm 
linearity (Annex 4b). For CBX and 1OH, the residuals appear to be randomly 
distributed. However, for IBU and 2OH, standard deviation problems are visible. 
Table 29. Regression parameters for synthetic wastewater calibration curves 
Compound Linear equation R2 r 
1OH y=0.0342x + 0.0004 0.9893 0.9946 
2OH y=0.0391x - 0.0034 0.9927 0.9964 
CBX y=0.0342x + 0.0002 0.9910 0.9955 
IBU y=0.0264x - 0.0068 0.9238 0.9611 
 
 The y-intercepts of the two 
curves were compared using 
student’s t-test (significance level α 
= 0.05) to assess for statistically 
significant difference, as described 
in Section 2.10.1. tcal were 0.28 
(2OH), 1.85 (1OH), 0.06 (IBU) and 
0.09 (CBX). There was no 
statistically significant difference 
between the curves as their t values are lower than tcri f=58 = 2.005.  
 
4.4 Capillary Electrophoresis 
4.4.1 Method Development and Optimization  
 
Preliminary analysis was performed using 10 mM borate buffer (pH 9) as BGE. 
Individual migration times were identified and effective mobilities from pH 0 to 12 
were calculated. The response function had its maximum value at pH 5. The effective 
mobility curves for each compound and response function were plotted as a function 
of pH (Figure 31). Experiments in acetate buffer were performed to confirm the 
suitability of this pH. Buffer concentration, hydrodynamic injection mode and 
separation voltage were tested (Table 17). Figure 32 shows the best conditions (50 
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Figure 30. HPLC calibration curve for 2OH in synthetic 
wastewater 
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mM, normal polarity, 20kV) identified for compound separation and order of elution. 
The isomers 2OH and 1OH were identified the critical peak pair. 
During the experiments, high migration times and broad peak shape were 
observed for CBX. Additionally, the peak did not appear in some experiments 
performed to verify reproducibility of the separation conditions. This behaviour can 
be explained by the conversion of the acidic compounds to anions at this pH. As a 
double anion, due to the deprotonation of its carboxylic acid groups, CBX has the 
slowest effective mobility and migrates against the EOF, towards the anode. The EOF 
and ionic strength of the buffer is too low to overcome this effect, due to high buffer 
concentration (50 mM). CBX may therefore either migrate slowly to the detector or 
its peak is not visible on the electropherogram as it exists the capillary towards the 
anode236,258,267. Reducing the capillary length improved migration time but did not 
correct its problem of erratic non-detection. With this evaluation, it was decided to 
assess the separation of the compounds using borate buffer (pH 9), which is 
recommended to create conditions for faster effective mobilities for the four anions246. 
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Testing of Separation Factors in Borate Buffer 
 
Buffer concentration (10, 15, 20, 25 and 30 mM), surfactant type (SDS, 
CTAB), surfactant concentration (20, 30 and 40 MM for SDS; 0.2 mM for CTAB), 
organic solvent and percentage of organic solvent (methanol–10%, acetonitrile –10, 
20%, THF–5, 10, 15 and 20%), and separation voltage (20 and 25 kV) were examined 
to identify possible separation conditions (Table 17). Critical pair separation was 
difficult to achieve. Initially, one factor was varied with the others kept at constant 
level due to unavailability of literature on the separation of these compounds. 
Migration time increased proportionally to buffer concentration and percentage of 
organic solvent, but did not change selectivity. Varying organic solvent and addition 
of only SDS and cetrimonium bromide did not produce separation. SDS concentration 
above 40 mM increased buffer viscosity and the likelihood of high current and Joule 
effects. Unexplainable, peaks were not observed with CTAB. Their mobilities may 
have been too fast for detection at that voltage. 20kV was chosen as the separation 
voltage for subsequent experiments as higher voltages increased current and potential 
for Joule effects while lower voltages increased migration and analysis times.  
Separation of the critical pair was finally obtained under MEKC conditions 
with 20 mM borate, 20 mM SDS and 10% THF. The elution order was 2OH, 1OH, 
IBU and CBX. Concentration controlled selectivity by decreasing electrolyte ionic 
strength and EOF, leading to changes in electrophoretic mobilities of the analytes270. 
Increasing buffer concentration above 20 mM lengthened the migration time of CBX 
and analysis time with slight improvement to critical resolution.  
SDS changes the selectivity of these hydrophobic compounds by increasing 
their solubility and reducing hydrophobic interactions for decreased mobility that 
separates the isomers 238,274,275. This was reflected in the higher migration times 
observed with SDS addition compared with those in borate buffer only. As an anionic 
surfactant, SDS micelles electrostatically migrates towards the anode. Yet, normal 
polarity can be used for separation as EOF velocity prevails to carry the micelles 
towards the cathode and detector, albeit with slow migration (Figure 33)260,275.  
In MEKC, organic solvents change selectivity by the dual effect of decreasing 
EOF by increasing viscosity and modifying the partition coefficient of the 
hydrophobic compounds between the micelles and electrolyte260,272. Consequently, 
both separation and migration of the compounds increase. Methanol and acetonitrile 
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are more commonly used, however the aprotic THF was selected for its potential to 
create better selectivity between the two isomers. THF has been applied to CE to 
successful separation of quinolones which have similar pKas and functional groups 
(carboxylic acid) as the compounds of this study 315. Research has shown the better 
capacity of THF to disrupt hydrogen bonds and interact with OH groups in 
comparison to methanol316.The presence of the two methyl groups at the 20carbon 
atom in 2OH, creates a crowded space for more steric hindrance of hydrogen bond 
formation between the OH group and THF, compared to the position of the OH group 
in 1OH. This results in weaker hydrogen bonding between 2OH and THF promoting 
the selectivity difference between the two isomers 317. It was observed that increasing 
THF above 15% resulted in a high migration time of CBX and resulting analysis time. 
 
 
 
 
 
 
 
 
 
Optimization of Separation Conditions and Evaluation of Response Functions 
 
Full factorial experimental design (Tables 22 and 23) was performed to 
optimize critical resolution with buffer concentration, % THF and SDS concentration. 
The levels were set from the preliminary experiments to give separation and avoid 
high current and Joule effects. The results are shown in Figure 34. It was observed 
that increasing buffer concentration, SDS concentration and %THF improved 
resolution of the critical pair and overall peak resolution. The calculated response 
functions (Section 2.6) are displayed with the runtime in Table 30. The quality of 
separation (low CRS, low CEF, high CRF, high Rsum and high Rcp) was evaluated. 
 
Table 30. Response function results for the 23 factorial design 
Electrolyte CRS CRF CEF Rsum Rcp RP Runtime 
(min) 
1 10 60 408 38 1.0 2 7.0 
2 11 57 308 37 1.1 2 7.5 
3 2.0 66 7.8 39 1.8 4 7.0 
4 3.6 68 7.8 43 2.2 4 8.5 
5 59 72 32 54 1.5 2 9.5 
6 27 69 47 52 1.4 2 10 
7 5.3 77 10 56 2.7 4 11 
8 5.8 79 11 60 3.5 4 12.5 
Figure 33. Representation of MEKC separation with SDS275 
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The CRS and CEF ranks experiment 3 as the best condition followed by 4, 7 
and 8. Experiments 8 followed by 7 has the highest CRF, Rsum and Rcp. Experiments 
3, 4, 7 and 8 have all peaks separated. Evaluating all response functions, the 
conditions of experiment 3 (15 mM borate, 40MM SDS, 10% THF) were selected due 
to complete separation of all four compounds, critical resolution of 1.8 and short 
runtime. Figure 35 shows the initial optimized conditions including the suitability of 
benzoic acid as internal standard as it did not coelute with the target analytes. 
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Figure 34. 23 factorial designed electropherograms 
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Analysis in synthetic wastewater showed no interferences with the elution of each 
compound and similar retention times and resolution (Annex 5). 
 
 
 
 
 
 
 
 
 
 
In subsequent analysis, critical resolution (≥ 1.5) was no longer achievable with 
these conditions. The separation conditions of experiment 7, 15 mM borate, 40 mM 
SDS and 15% THF, were therefore selected for the largest critical pair resolution and 
positive evaluation with all response functions. This was used to perform method 
validation. This effect is possibly to the modifications of the capillary wall surface 
that occur in CE analysis due to the BGE and sample258,260. This buffer in combination 
with SDS was frequently used for NSAID separation as earlier discussed. Problems 
with changing conditions were not reported. Some researchers condition the capillary 
in between runs to avoid this problem, however attempts to return to the experiment 3 
conditions by conditioning of the capillary or changing the capillary were not 
successful. Figure 36 shows the final optimized separation conditions achieved with 
stacking (water plug injected 16s after the sample). The migration times are given in 
Table 31. An analytical run was performed using 15 mM borate, 40 mM SDS with 20 
% acetonitrile, the latter is equivalent to 10% THF. Methanol was not tested as longer 
analytical times are usually observed 233. A longer runtime (9.5 min) and lower critical 
resolution (1.7) was observed in comparison to the optimized conditions (Annex 5). 
Additionally, baseline separation between the critical pair was not achieved. 
Table 31. Chromatography quality parameters for optimized MEKC method 
Compound Migration time Rs Column Efficiency Tailing Factor 
2OH 4.646  41581 1.0 
1OH 4.808 1.8 41138 0.9 
IBU 6.254 12.6 29844 0.9 
Benzoic acid 7.621 9.5 43468 1.0 
CBX 9.821 13.1 37547 1.1 
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4.4.2 Stacking 
On-line 
preconcentration was 
investigated as described in 
Section 3.5.3 using field 
amplified sample stacking 
with the electrolyte conditions 
of 15 mM borate, 40mM SDS 
and 10% THF. The placement 
of the milli-q water plug 
(before and after sample), length of injection of water plug (t=0, 2, 3, 5, 7, 10, 12, 16, 
18, 20, 30s), length of injection time for the sample (t= 3s, 6s), addition of organic 
solvent to the water plug in the same ratio as the electrolyte were examined. The 
solvent (milli-q water) has lower conductivity than the BGE. The technique was 
combined with an element of field-amplified sample injection by injection of a water 
plug into the capillary318. The compound peaks were not visible in experiments where 
the sample was injected electrokinetically. The injection of the water plug before the 
sample gave better peak heights (Figure 37). Injecting the water plug after the sample, 
tended to cause distortion in the CBX peak and smaller heights. Increasing sample 
injection time resulted in decreased critical resolution. In subsequent analysis, the 
separation conditions were changed to 15 mM borate, 40 mM SDS and 15% THF as 
shown in Figure 36. The water plug was modified to include 15%THF to improve 
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Figure 37. Peak heights obtained with injection of the water plug before the 
sample 
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Figure 36. MEKC separation using 15 mM borate, 40 mM SDS, 15% THF 
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peak shape. Higher peak shapes were now obtained with the water plug injected after 
the sample for 16s, influenced by the addition of the organic solvent to the water plug. 
The common practice is to inject the plug before the sample, followed by injection of 
anions in reverse polarity and finally switching to normal polarity for separation284–
286. By injecting water after the sample, the anions which migrate to the anode, stack 
at the back of the sample/electrolyte zone. This is opposite to the effect seen in Figure 
14. The strength of the BGE EOF carries the anions to the cathode and detector. A 
wavelength scan performed after the stacking experiments showing the highest 
compound absorbance at 200 nm. 
 
4.4.3 Method Validation 
 
Validation was performed in the solvent (milli-q water) as described in Section 
3.8. The results are shown in Table 32. 
Table 32. Validation parameters for MEKC curve in solvent 
Compound Linear equation r2 r LOD  
µg/L 
LOQ 
µg/L 
Range 
µg/L 
Precision 
 Repeatability 
%CV 
Intermediate 
Precision 
1OH y=0.05 9+ 0.0024 0.9600 0.9798 3.3 9.9 9.9 - 125 1.8 0.1 
2OH y=0.0569 + 0.0023 0.9680 0.9838 3.9 12 12 - 125 3.5 0.1 
CBX y=0.149x + 0.0096 0.9660 09829 5.1 15 15 - 125 2.7 0.2 
IBU y=0.053x - 0.0066 0.6341 0.7962 15 45 45 - 125 19 0.9 
 
Specificity was obtained from the separation of all four compounds and 
confirmation of their individual migration times in water (Figure 36). The critical pair 
resolution decreased to 1.7, which was lower than that observed in method 
optimization. Additionally, the migration time for each compound changed. However, 
the obtained resolution (≥ 1.5) was acceptable.  
Linearity was assessed for a working range of 15 –125 µg/L, based on the 
concentrations dosed to the SBRs (50 and 100 µg/L). Two calibration curves were 
prepared in solvent (milli-q water) and matrix (synthetic wastewater) respectively 
(Table 11). SPE provided a preconcentration factor of 200 bringing detection to the 
range of 3000 – 25,000 µg/L. Variances in the standard solution series was evaluated 
for statistically significant difference using Hartley’s Fmax test (Section 2.10.2). 1BU 
was the only compound that passed the test (Fmax values are shown in Annex 1b). The 
calibration charts were nevertheless plotted. The linear equation and regression 
parameters for each compound are shown in Table 32. The curve for 2OH is shown in 
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Figure 38 and the remaining 
curves are given in Annex 6a. 
Residual plots were prepared 
to assess linearity, particularly 
for IBU (Annex 6b). The 
plots show that standard 
deviation appears to increase 
with concentration. This 
could be due to matrix effect 
or volumetric errors during sample preparation292.  
LOD was determined using the residual standard deviation and deviation of the 
y-intercept obtained from a calibration curve of the three lowest concentrations. The 
value which is the ratio of compound concentration to concentration of BA, was 
converted to concentration by multiplying with BA concentration (5000 µg/L) and 
then dividing by the preconcentration factor of 200. The LODs passed the acceptance 
tests for correct calculation (Annex 6c), except for IBU, whose LOD was the same 
value as the minimum concentration. LOQ was calculated from LOD with CBX and 
IBU LOQs higher than the minimum calibration concentration. The range was 
determined as LOD concentration to the maximum calibration standard.  
Repeatability was obtained using solutions of 25, 50 and 100 µg/L. Outliers 
were assessed using the Dixon’s Q-test (Values given in Annex 1c). IBU and CBX 
passed the test, 2OH and 1OH did not. Variances in the standard solution series was 
evaluated for statistically significance difference using the Hartley’s Fmax test. 1OH 
passed the test, 2OH, IBU and CBX did not (Annex 1b). Repeatability was still 
calculated as the average %CV and was acceptable for three compounds except IBU 
according to AOAC recommendations for analyte concentration(<21 % for 10 ppb, 
<15% 100 ppb) 308. The solutions were injected on a second day to obtain 
intermediate precision, which was calculated as SD of all 36 measurements.  
   Method recovery was determined by calculating the concentrations obtained in 
three spiked solutions processed through SPE (25, 50 and 100 µg/L) from the 
calibration curve. The results are shown below in Table 33. 2OH, 1OH and CBX had 
overall reasonable recoveries according to AOAC recommendations (60 - 115% for 10 
ppb, 80-110% for 100 ppb)308. IBU had significantly high results which indicates 
possible matrix effects from the sorbent or sample preparation including pre-treatment. 
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Figure 38. MEKC calibration curve prepared for 2OH in milli-q water 
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Table 33 Recoveries obtained for the compounds in MEKC, n=1 
Concentration, µg/L 25 50  100 
Compound % Recovery 
2OH 104 103 105 
1OH 116 103 115 
IBU 211 134 1111 
CBX 112 107 107 
 
Comparison of the Solvent and Matrix Matched Calibration Curves 
  Statistically significant variance in the synthetic wastewater standards was assessed 
using the Hartley’s Fmax test. Only 1OH passed the test (Annex 1b). The calibration 
charts were nevertheless plotted. 2OH is shown in Figure 39. The curves for the 
remaining compounds are given in Annex 4. The regression parameters are given in 
Table 34. Residual plots were prepared to confirm linearity, especially for IBU (Annex 
6). For 2OH and 1OH, the residuals appear to be randomly distributed, however with 
great variation in the standard deviations. A problem of increasing standard deviation is 
visible for IBU and CBU.  
Table 34. Regression parameters for synthetic wastewater calibration curve  
Compound Linear equation R2 r 
1OH y=0.0505x + 0.0142 0.9714 0.9855 
2OH y=0.0457x + 0.0122 0.9798 0.9898 
CBX y=0.18242 - 00817 0.9838 0.9918 
IBU y=0.1195x - 0. 817 0.3224 0.5678 
 
  Comparison of the y-
intercept of the two curves using 
student’s t-test (significance level 
α = 0.05) as described in Section 
2.10.1 showed statistically 
significant difference between 
the curves. tcal values were 10.4 
(2OH), 9.1 (1OH), 3.3 (IBU) and 
12.5 (CBX), which are higher 
than tcri f=70 = 1.994.  
4.5 Application of HPLC and MEKC Methods to Real Samples 
 
  Despite, the poor validation results, both methods were applied to analyse 
samples taken from the aerobic SBRs as described in Section 3.3.3. The methods were 
used to assess the system’s ability to degrade ibuprofen or if ibuprofen and its 
metabolites were present in quantifiable amounts. The reactors were dosed with 50 and 
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Figure 39. CE calibration curve for 2OH in synthetic wastewater 
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100 μg/L on day 21 and 27 respectively. Synthetic wastewater and milli-q water 
controls were used to evaluate if degradation occurred due to the system or other 
means. The controls were prepared at the same time as the reactor influent containing 
ibuprofen and dosed in the same concentration tested. The controls were not passed 
through the reactor, but allowed to stand for the length of the cycle during which 
sampling was performed. Analysis was performed only for the 50 µg/L samples due to 
limited number of SPE cartridges. 
  A total of 16 samples was analysed.  The solvent calibration curve was used to 
analyse the samples for both methods, although there was statistically significant 
difference between the solvent and matrix curves for the MEKC method. This was 
performed due problems with method robustness that limited analysis time for 
submission of data to thesis deadline. In MEKC, CBX was the only compound 
detected in method limits, in two samples (Annex 5 shows an electropherogram of a 
sample where no compound was detected). These were found in sample T5 taken from 
the aerobic reactor corresponding to 150 min and in the synthetic wastewater control. 
2OH, 1OH and IBU were not detected in any samples. However, the concentrations 
calculated using the solvent calibration curve for both samples were extremely high 
and exceeded method range. This could be the result of several factors. As discussed in 
Section 1.5, CBX tends to be the prevalent metabolite in ibuprofen degradation20,27–33. 
Degradation could have occurred in the granules to concentrations below method 
detection limits. Additionally, linearity (r< 0.99) for CBX calibration curve was poor, 
which would influence calculated concentrations.  
  In HPLC, no peaks corresponding to CBX were detected in any sample 
including the control and T5 aerobic. 1OH was the only compound detected. Figure 40 
shows the difference in the compounds detected in each method. The 1OH 
concentrations calculated for the synthetic wastewater control, water control and the 
sampling time points are illustrated on Figure 41. Calculated 1OH values were 
significantly high and exceeded method range. The anaerobic reactor has the lowest 
concentration at the end of the time cycle. While the aerobic reactor has the highest 
concentration during aeration and at the end of the cycle. This SBR therefore seems 
less efficient at removing at least one metabolite. Both SBRs appear to degrade IBU, 
2OH and CBX in both anaerobic/aerobic and aerobic operating cycles. This has great 
potential as generally ibuprofen degradation requires highly aerobic conditions and 
contrasts with the study of Zhao et al, which observed only 34 – 45% removal204.  
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  Ibuprofen was not detected in the synthetic wastewater and milli-q water 
controls by either method. It has been observed that metabolites have been detected in 
WWTP influent, indicating the degradation of the compound before entry to 
WWTP32,87,102.  It may be possible that this same effect occurred in the controls, 
however repetition of the experiments is required for verification. It is possible that 
some degradation could have occurred during transport of the samples for analysis to 
Brazil. The samples were lyophilized but were detained for one month by the national 
customs agency. The delay under transport and storage conditions may have 
compromised results.  
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4.6 Comparison of the Methods and Robustness 
The methods detected different analytes, therefore instead of student’s t test, 
they were compared on validation parameters. Both methods gave selectivity and 
separation of the compounds. Analysis time was also comparable. However over time, 
the conditions in both methods show signs of problems with robustness. Robustness 
was a larger problem with CE. Much time was spent trying to reproduce separation 
conditions. CBX peak distortion was observed in some analytical runs and decreasing 
resolution of the critical peak pair (Figure 42). For HPLC, a problem appeared when 
analysing the low concentrations of the calibration curve, which could account for the 
repeatability results for 2OH. The resolution between benzoic acid and the first 
compound peak, 2OH decreased below the recommended limit to 1.2 (Figure 43). 
This peak distortion affected precision results. Both methods experienced a 1-2% 
variation in retention time, which is common given daily lab work. However, this may 
have contributed to distortion of the CBX peak. For HPLC, a significant difference in 
compound peak height was observed in 50 µg/L standard preparation for the SPE 
trials compared with the solvent calibration curve (Annex 2). 
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Figure 43. Chromatogram of benzoic acid merged with 2OH in standard concentration 15 µg/L 
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The validation results obtained for each method are compared in Table 35. 
Recoveries were highly variable between both methods, concentrations tested and 
compounds. For HPLC, recoveries within AOAC guidelines were achieved for 2OH, 
1OH and IBU had both high and low recoveries while CBX had very low recoveries. 
In contrast, 2OH and 1OH had recoveries within AOAC guidelines in the MEKC 
method, while the majority for CBX recoveries were low. IBU recoveries were 
unrealistically high. HPLC gives better linearity and intermediate precision for 2OH 
1OH and CBX. IBU has poorer linearity in HPLC compared with MEKC, but the 
former provides better intermediate precision. Method sensitivity (LOD and LOQ) for 
all compounds is higher in HPLC than MEKC, despite the use of both off-line and on-
line preconcentration for MEKC. This is most likely due to the observed deterioration 
in experimental conditions. Repeatability for 1OH, CBX and IBU was superior in 
HPLC, while 2OH has best results in MEKC. Both methods experienced failure of 
some standard solution results to meet the statistical tests for repeatability and 
linearity. Further statistical treatment observed that the methods would pass the 
statistical tests only with the reduction of the working range to 15 – 100 µg/L and 
reduction in the number of replicates. SPE, HPLC and MEKC validation will have to 
be repeated to achieve methods properly suited for their intended application.  
4.7 Comparison to Published Literature 
A comparison of the validation results, experimental conditions and application 
of the HPLC and MEKC methods to four published studies that investigated these 
compounds are given in Tables 35 and 3627,29,30,142. These studies investigated the 
biodegradation of ibuprofen and its metabolites and detection in aquatic matrices.  
The SPE procedure used in this study was adapted from Paíga et al.29 and 
several authors22,27,29,72,147,212,240,298,299. Polymer sorbents were used as the compounds 
were analysed with other pharmaceuticals with the exception of Ferrando-Climent et 
al27. Validation recoveries were published only by Ferrando-Climent and Paíga. Most 
of the recoveries observed by Ferrando-Climent and Paíga using Oasis HLB and 
Strata-X polymer SPE cartridges were close to AOAC guidelines and met the United 
States Environemtal Protection Agency recommendations for LC-MS/MS methods319.  
The four methods couple LC analysis to mass spectrometry detectors, in 
contrast to the UV/Vis detectors used, to enhance method sensitivity and selectivity. 
The HPLC mobile phase of this study is similar to Boix et al with the substitution of 
acetonitrile as solvent B30. Ferrando-Climent and Paiga assessed the possibility of 
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matrix effect arising from differences in the sample matrix and calibration standard 
solution matrix.  Ferrando-Climent observed no matrix effect while Paiga noted ion 
enhancement for ibuprofen. Both applied internal standard calibration to correct for 
this effect. 
Ferrando-Climent, Larsson and Paiga published results of validation for 
linearity, LOD, LOQ and precision. Linearity, expressed in these papers as r2, was 
established, with all values > 0.99. Precision (repeatability and intermediate precision) 
were comparable to those obtained in this study for HPLC and MEKC. Ferrando-
Climent, and Paiga had greater method sensitivity than the HPLC and MEKC 
methods, with LOD and LOQs in ng/L levels. However, the methods of this study had 
lower LODs and LOQs than Larsson et al. due to the selected working range. 
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Table 35. Comparison of validation results of HPLC, MEKC and other methods developed for compounds of study 
Study r2 LOD  
μg/L 
LOQ 
μg/L 
Calibration curve 
range 
μg/L 
Precision % Recoveries, %RSD 
Repeatability 
%CV 
Intermediate 
Precision 
1OH 
HPLCa 0.9766 3.2 9.5 15-125 1.0 (n=5) 0.05 (n=5) 124; 103; 105 (n=1) 
MEKCa 0.9600 3.3 9.9 15 - 125 1.8 (n=6) 0.1 (n=6) 114; 110; 130 (n=1) 
Ferrando-Climent et 
al., 201227 
0.9975 0.02232b 
0.01723c 
0.01664d 
0.0742 b 
0.0572 c 
0.0554 d 
0.1 -100 1.61 (n=5) 0.16 (n=5) 87.6 (5.8%); 79.0 (6.9%); 75.0 (3.4%) 
(n=3) 
Larsson et al., 2014142 0.9982 28.2 93.9 250-2000 <9 <9 Not provided 
Paíga et al., 2015 29,,e 0.9974 0.0039 0.0118 0.1-1000 
Linear range: 5-100 
4.48 (n=6) 2.70 (n=6) 85.2 (2.8%); 80.5 (2.5%); 83.7 (2.8%) (n=3) 
2OH 
HPLC1 0.9795 3.8 11 15-125 9.4 (n=5) 0.04 (n=5) 75; 94; 99 (n=1) 
MEKC1 0.9680 3.9 12 15 - 125 3.5 (n=6) 0.1 (n=6) 104; 103; 105 (n=1) 
Ferrando-Climent et 
al., 2012 
0.9979 0.0210 b 
0.0163 c 
0.0101 
0.0699 b 
0.0545 c 
0.0336 d 
0.1 -100 2.12 (n=5) 12.61 (n=5) 41.1 (16.2%); 70.8 (2.7%); 119.8 (0.8%) 
(n=3) 
Larsson et al., 2014 0.9995 21.0 d 69.9 250-2000 <9 <9 Not provided 
CBX 
HPLC1 0.9803 4.3 13 13 -125 1.6 (n=5) 0.04 (n=5) 122; 106; 102 (n=1) 
MEKC1 0.9660 5.1 15 15 - 125 2.7 (n=6) 0.2 (n=6) 11; 107; 10 (n=1) 
Ferrando-Climent et 
al., 2012 
0.9909 0.0234 b 
0.0232 c 
0.0085 d 
0.0781 b 
0.0073 c 
0.0285 d 
0.1 -100 3.22 (n=5) 14.80 (n=5) 190 (19.0%); 74.5 (1.6%); 58.8 (4.4%) (n=3) 
Larsson et al., 2014 0.9990 58.0 193.1 250-2000 <9 <9 Not provided 
Paíga et al., 2015 0.9925 8.18 24.8 Linear range 100 -
1000 
2.47 (n=6) 0.4 (n=6) 68.7 (5.8%); 68.2 (3.0%); 65.8 (4.3%) 
IBU 
HPLC1 0.7477 7.5 23 23 -125 2.5 (n=5) 0.04 (n=5) 130; 110; 127 (n=1) 
MEKC1 0.6341 15 45  45 - 125 19 (n=6) 0.9 (n=6) 211, 134, 1111 (n=1) 
Ferrando-Climent et 
al., 2012 
0.9998 0.0200 b 
0.0021 c 
0.0007 d 
0.0665 b 
0.0069 c 
0.0024 d 
 0.1 -100 0.31 (n=5) 2.70 (n=5) 193.1 (2.0) 70.9 (12.4) 84.8 (0.1) (n=3) 
Larsson et al., 2014 0.9996 44.2 147.2 250-2000 <9 <9 Not provided 
Paíga et al., 2015 0.9957 0.00008 0.00026 Linear range 10 -100 2.59 (n=6) 8.10 86.5 (2.2%); 89.5 (4.3%); 89.0 (4.0%) (n=3) 
aThis study bWWTP influent  c WWTP effluent  d River water  eDid not study 2OH 
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Table 36. Comparison of experimental conditions and extraction procedure of HPLC, MEKC and other methods applied to compounds of study 
Study Research Sample matrix  Calibration 
standard 
solution solvent 
Technique/Detector Mobile Phase Analysis 
time 
(min) 
Extraction 
Method 
Technique 
HPLCa Aerobic granule 
degradation and 
removal of IBU, 
2OH, 1OH and 
CBX 
synthetic 
wastewater 
milli-q water HPLC/ UV/Vis Water (solvent A), 
acetonitrile (solvent B), 
both acidified with 
0.01% formic acid (v/v) 
16 SPE Strata C18e 
(200 mg, 6 mL) 
Section 3.2 adapted procedure from Paíga 
et al. 2017 and several 
authors22,27,29,72,147,212,240,298,299 
MEKCa MEKC/UV/Vis 15 mM borate, 40 mM 
SDS, 15% THF 
15 
Ferrando-
Climent et 
al., 2012 
Biodegradation 
batch experiments 
of IBU in WWTP 
activated sludge 
WWTP influent 
WWTP effluent 
river water 
methanol-water 
(10:90, v/v) 
UPLC-MS/MS, 
gradient elution, C18 
column, internal 
standard calibration 
(ibuprofen-d3) 
5 mM ammonium 
acetate pH 8(solvent A) 
Methanol (solvent B) 
6.7 SPE Oasis HLB 
(60 mg, 3 mL) 
Adapted procedure79 
Sample pretreatment: 
ethylenediaminetetraacetic acid disodium 
to adjust pH to 4.5. 
Conditioning solvents, methanol, HPLC-
grade water 
Wash solvent: HPLC- 
grade water 
Drying: under vacuum 15 min 
Elution solvent: methanol 
Reconstitution solvent: Methanol-water 
(10:90, v/v) 
Larsson et 
al., 2014 
Identification of 
ibuprofen and 
metabolites with 
other NSAIDs in 
wastewater 
WWTP influent 
WWTP effluent 
 
0.1 M 
ammonium 
carbonate 
buffer, 
pH 9 
LC-MS/MS, LC-MS, 
standard addition, 
isocratic 
10 mM ammonium 
acetate pH 4 (solvent 
A) 
Methanol (solvent B); 
40:60, v/v 
14 Hollow fibre 
liquid phase 
microextraction: 
Acceptor buffer 0.1 M ammonium 
carbonate solution with 
pH 9 
Boix et. al., 
201630, b 
Degradation of 
ibuprofen and 
other 
pharmaceuticals 
in activated 
sludge batch 
experiments  
surface water 
Mineral media 
Not described UPLC-time-of-flight 
mass spectrometry, 
gradient 
Water (solvent A), 
methanol (solvent B) 
both acidified with 
0.01% formic acid 
14 – 18 Oasis HLB, 60 
mg 
Not described 
Paíga et al., 
2015 
Determination of 
NSAIDs in 
seawater 
seawater acetonitrile–
ultra-pure water 
(30:70, v/v) by 
UPLC-MS/MS, 
C18 column, internal 
standard calibration 
(ibuprofen-d3) 
Ultra-pure water 
(solvent A), methanol 
(solvent B)  
10.5 SPE Strata-X 
(200 mg, 3 mL) 
Strata-X cartridges (200 mg) 
Conditioning solvents, methanol, ultra-
grade water pH 2 
Wash solvent: ultra- 
grade water 
Drying: under vacuum 1 hr 
Elution solvent: methanol 
Drying: nitrogen 
Reconstitution solvent: acetonitrile–ultra-
pure water (30:70, v/v)  
aThis study     bDid not provide validation data
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4.8 Performance of Aerobic Granule SBRs 
Two aerobic granule SBRs were operated in different conditions as described 
in Section 3.3.1 and 3.3.2. The SBRs were constructed by adapting material available 
in the laboratory, therefore the dimensions were smaller than those used in previous 
aerobic granule studies with pharmaceuticals 198–203. The SBRs were dosed with 
ibuprofen at two concentrations (50 and 100 µg/L) to assess the ability of aerobic 
granules to biodegrade ibuprofen and the efficiency of removal. Identical pumps were 
initially used for both reactors, however due to failure, the reactor 2 pump was 
replaced. Hydraulic retention time was 5.4 hrs and influent loading rate was 0.120 
m3/m2 per day. The measured pH ranged from 7.4 to 8.4. Dissolved oxygen was 8.26 
mg/L.  
SBR performance was evaluated by COD (Figure 44), phosphorus (Figure 45) 
and ammonia removal (Figure 46). COD removal was initially higher in reactor 1. 
However, removal in reactor 2 increases until the performance of reactors is 
comparable (approximately 90%). Under normal SBR operating conditions (reactor 
2), most COD consumption by the microorganisms occur in the anaerobic phase. 
Early aerobic granule SBRs had a short feeding period as applied to the SBRs in this 
study, until research proved that longer feeding periods were required to maintain 
granule stability at full-scale operation191. Phosphorus removal, which occurs during 
the aerobic stage, was initially higher in reactor 1 but the removal in reactor 2 
eventually improved and surpassed. However, the maximum observed removal of 
14%. Low phosphorus removal is a consequence of competition between 
polyphosphate and glycogen accumulating organisms for COD uptake 162,201 
Ammonia removal was higher in reactor 1 until day 27 when the removal in both 
reactors were comparable. Similar COD, phosphorus, nitrogen removal profiles were 
observed in previous aerobic granule SBR studies with pharmaceuticals.   
 A comparison of nitrogen concentration in the influent and effluent of both 
reactors is shown in Figure 47.  Nitrogen effluent concentration was initially lower in 
reactor 1 at day 14. Subsequently, reactor 2 showed the best removal of nitrogen until 
days 21 and day 27 when nitrogen concentration was higher in the effluent of both 
reactors in comparison to the influent. This indicates the suppression of 
denitrification, causing nitrogen accumulation and could be the result of two factors. 
Firstly, the accumulative effects of the constant high dissolved oxygen in the reactors 
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which reduces granule nitrification ability. Ammonia and nitrogen removal is 
generally good in previous studies where dissolved oxygen was monitored but not 
controlled. However larger reactors were used than those employed in this study, 
which could a role in reducing this effect. Secondly, this occurred after the addition of 
ibuprofen to the SBRs. Amorim et al. and Shi et. al observed this effect in aerobic 
granule SBRs dosed with chiral pharmaceuticals and tetracycline respectively198,201. 
The addition of ibuprofen on day 21, also appeared to significantly reduce phosphorus 
removal. However, reactor performance recovered to normal levels, even with the 
addition of ibuprofen on day 27, indicating granule adjustment to ibuprofen. 
Confirmation of the effect of ibuprofen in producing these removal profiles is 
required by comparison to SBRs operated with no introduction of ibuprofen. 
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After one month of operation, filamentous bulking and slime in the aerobic 
granules was observed, indicating possible nutrient deficiency. Fungal growth was 
also observed in the influent containers. Acetate concentration in freshly prepared 
synthetic wastewater, influent and effluent respectively was analysed by HPLC. The 
results confirmed that acetate concentration of the influent introduced to the SBRs 
was low, therefore the granules were not receiving the carbon load needed to maintain 
stability and form. It is possible that degradation in the influent reservoir is occurring 
as the influent is stored in between cycles. The operations of both SBRs was halted 
until a solution could be implemented to avoid this problem. 
Granule Measurements  
The SBRs were started with 
aerobic granules (2 g/L, total 
suspended solids) from the Águas de 
Portugal Nereda® Frielas WWTP in 
Lisbon, Portugal. The TSS of the 
supply was measured at 10.3 g/L. 
After 17 days, the granule layer increased by 61%. The SVI5 as 25 secs. The size of 
the granules ranged from 2 to 5 mm with the average size of 3 ±1.2 mm (Figure 48). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 48. Aerobic granules used to as start-up 
inoculum for SBRs 
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5. Conclusions  
 
Two aerobic granule SBRs were operated in synthetic wastewater at laboratory scale in 
anaerobic/aerobic and aerobic cycles respectively to assess the ability of aerobic granules to 
degrade ibuprofen and its dependence on operating cycle. Samples were taken from the 
reactors which were dosed with 50 and 100 μg/L of ibuprofen. Operation was halted due to 
acetate degradation reducing the carbon load to the granules arising from the growth of 
filamentous bulking and slime in the aerobic granules and fungi in the influent container.  
A HPLC gradient method and a MEKC method using UV/Vis were developed and 
optimized for the separation and analysis of ibuprofen and its three metabolites in the SBR 
samples. Preconcentration of the environmentally realistic concentrations (µg/L) to ppm level 
was performed off-line using SPE for HPLC, while both off-line with SPE and on-line 
techniques with FASS were utilized for MEKC. Interestingly, a new technique for FASS was 
explored by combining elements of FASI with the injection of a water plug after the sample 
instead of the standard method of injecting the plug before the samples. Its simplicity in 
removing the need to switch polarity, could be further explored for a new technique for 
application to anion analysis and on-line preconcentration.  
 Validation was performed in solvent to determine selectivity, linearity, LOD, LOQ, 
range, precision, recovery and robustness applying ICH and AOAC principles. Achieving 
selectivity was difficult for 2OH and 1OH in CE and 2OH and CBX in HPLC but eventually 
the compounds could be separated. It was observed that although separation conditions could 
be achieved in CE, the conditions were not robust.  
The results of the remaining parameters could not confirm the validity of the methods 
for their intended application. Highly variable recoveries were obtained in experiments to 
evaluate the SPE procedure and validation of both methods. Some results complying with 
AOAC guidelines (80-110%) and corresponded to published literature, while unrealistically 
high recoveries ranged from 119 – 1111% and was not consistent to a particular compound. 
Both methods had results for linearity and repeatability that failed to pass the Harley’s Fmax 
test and Dixon’s Q-test indicating statistically significant difference in the variances of the 
standard solutions of the calibration curve and solutions used to assess repeatability and the 
presence of outliers. Linearity in the desired working range could not be confirmed. 
Calibration curves were still prepared and repeatability calculated due to limitations on time 
for thesis submission. Repeatability was acceptable (< 15%) in both methods except for IBU 
in the MEKC method. Calculated LOD passed all tests for accuracy of calculation. However, 
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LODs for IBU in both HPLC and MEKC and CBX in MEKC, were higher than the minimum 
standard concentration used for the calibration curves.  Solvent and matrix calibration curves 
were compared using student’s t-test for statistically significant difference and matrix effect. 
There was no significant difference between the curves for HPLC but the MEKC method 
failed to pass the test.  
The methods were applied to the SBR samples. Each method detected a different 
analyte. MEKC detected CBX in contrast to HPLC, which detected 1OH. The concentrations 
of the other compounds were below method detection limits.  
Despite the problems experienced, both methods are excellent starting points for further 
improvement and application for simple environmental analysis of ibuprofen and its 
metabolites. Some of the validation results were comparable to published literature. The 
methods show potential for application to ibuprofen environmental analysis once investigation 
to address experimental problems and revalidation is performed. 
Limited research has been undertaken thus far to investigate the potential of aerobic 
granules as a wastewater treatment that can address the global problem of pharmaceuticals as 
emerging environmental pollutants. In literature review, no studies were identified that 
considered the metabolites, which can have similar or more toxic environmental effects, in 
addition to the parent compound. 
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6. Future Perspectives 
 
Further work is required to verify that aerobic granules can degrade ibuprofen and its 
metabolites in both aerobic and anaerobic/aerobic operation and to confirm the suitability of the 
developed HPLC and MEKC methods for their intended application to the SBRs. The 
following recommendations are proposed for continuation of research: 
 
Methods 
1. Re-evaluation of SPE Procedure: The SPE procedure must be repeated for evaluation of 
suitability for preconcentration of these compounds, using at least 3 replicates per 
concentration. A comparison of the recoveries obtained using polymer SPE cartridges 
(Strata-X, Oasis HLB or Oasis MCX) should be performed. If the same recoveries are 
obtained, adjustment of the washing solvent by addition of organic solvent (starting at 5%) 
to remove possible interferents can be considered, Due to desired investigation at trace 
concentrations, the use of micropipettes cannot be avoided.   
2. Revalidation: The validation must be performed again for all compounds to confirm 
linearity in the desired working range and acceptable repeatability with results that meet 
the applied statistical tests for acceptability of results. The obtained LOD and LOQ of both 
methods also require improvement of sensitivity to be for both methods to be comparable 
to other published methods in surface and ground waters (ng to low μg/L). The compounds 
may be present in analysed samples, but at concentrations below method limits. 
Revalidation will also be required for method transfer to UAlg. 
3. Reanalysis of Samples: Both methods detected different analytes. Reanalysis of the 50 
μg/L samples is required to verify the validity of these results. The 100 μg/L samples 
should also be analysed for comparison of detected compounds. 
SBR 
The reactors appear to degrade ibuprofen, however, experiments should be repeated to 
for verification due to unrealistically high results. A method of influent preparation and 
introduction is required to introduce the carbon source immediately before the cycle to the 
reactors. This should address the problem of competing organism growth in the influent 
containers. Confirmation of the effect of ibuprofen in producing the removal profiles 
observed in this study should be conducted by comparison to SBRs operated with no 
introduction of ibuprofen.  
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8. Annexes 
 
Annex 1. Statistical Tests and Critical Tables311 
a. Student’s t test: comparison of the means of two results 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
HPLC: tcal values for comparison of calibration curves, tcrit (f=58, α = 0.05) = 2.005 
Compound Calibration Curve y-intercept SD Absolute value tcal 
1OH solvent 0.0025 0.00627 1.836 
matrix 0.0142 0.00445 
2OH solvent 0.0012 0.00537 0.280 
matrix 0.1225 0.00339 
CBX solvent -0.0658 0.02082 0.058 
matrix -0.0818 0.13668 
IBU solvent 0.0096 0.01444 0.085 
matrix 0.04401 0.00793 
 
MEKC: tcal values for comparison of calibration curves, tcrit (f=70, α = 0.05) = 1.994 
Compound Calibration Curve y-intercept SD Absolute value tcal 
1OH solvent 0.0025 0.00627 10.4 
matrix 0.0142 0.00445 
2OH solvent 0.0012 0.00537 9.1 
matrix 0.1225 0.00339 
CBX solvent -0.0658 0.02082 3.3 
matrix -0.0818 0.13668 
IBU solvent 0.0096 0.01444 12.5 
matrix 0.04401 0.00793 
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b. Hartley’s Fmax test for statistically significant variance in measurement series 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
HPLC: Fmax values for Linearity and Precision 
Compound Fmax, 
Fmaxo (k=5, f=4, α = 0.05): 29.5 Fmaxo (k=3, f=4, α = 0.05) 15.5 
Linearity HPLC solvent Linearity HPLC 
matrix 
Repeatability for solvent 
curve  
1OH 31.9 20.7 2.6 
2OH 7.9 105.6 236.5 
CBX 6.5 35.4 2.8 
IBU 10.8 958.4 35.8 
 
MEKC: Fmax values for Linearity and Precision 
Compound Fmax, 
Fmaxo (k=6, f=5, α = 0.05):18.7 Fmaxo (k=3, f=4, α = 0.05) 10.8 
Linearity CE solvent Linearity CE 
matrix 
Repeatability for solvent 
curve  
1OH 24.8 5.4 6.9 
2OH 19.4 24.1 52.3 
CBX 24.0 23.6 30.6 
IBU 7.6 39.3 23.4 
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c. Dixon’s Q-test for outliers in results 
 
 
 
 
 
 
 
 
 
 
HPLC: Q1, Qn for the compounds in water for HPLC repeatability, n=5, Qcrt (α = 0.05) = 0.642 
Compound Q1 Qn  
2OH 0529, 0.393, 0.198 0.059, 0.438, 0.758 
1OH 0.280, 0.482, 0.144 0.440, 0.139, 0.316 
IBU 0.062, 0.071, 0.393 0.375, 0.286, 0.159 
CBX 0.165, 0.100, 0.530 0.140, 0.100, 0.061 
 
 MEKC: Q1, Qn for the compounds in water for MEKC repeatability, n=6, Qcrt (α = 0.05) = 0.560 
Compound Q1 Qn  
2OH 0.083, 0.067, 0.429 0.750, 0.200, 0.214 
1OH 0.123, 0.098, 0.082 0.131, 0.617, 0.428 
IBU 0.016, 0.137, 0.178 0.430, 0.528,0.467 
CBX 0.355, 0.307, 0.133 0.249, 0.266, 0.200 
 
d. Confidence Interval 
Mean ± z x SD    z value for 95% confidence interval = 1.96 
                   √n 
 
 
 
 
 
 
 
 
 
123 
Annex 2. SPE Results 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chromatogram of SPE trial, preparation 3, 50 µg/L in 100 mL milli-q water 
1 
2 3 
4 
5 
Peaks 1: BA, 2: 2OH, 3: CBX, 4: 1OH, 5: IBU 
Chromatogram of SPE trial, preparation 3, 50 µg/L in 200 mL milli-q water 
1 
2 3 
4 
5 
Peaks 1: BA, 2: 2OH, 3: CBX, 4: 1OH, 5: IBU 
Chromatogram of 50 µg/L method validation calibration curve standard processed by SPE 
1 
2 
3 
4 
5 
Peaks 1: BA, 2: 2OH, 3: CBX, 4: 1OH, 5: IBU 
124 
 
Annex 3. HPLC Method Development Calculations and Chromatograms 
 
a. UAlg 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
UAlg: Retention factor for mobile phases tested in experimental design 
Mobile Phase Retention factor, k 
1OH 2OH CBX IBU 
10 mM ammonium acetate buffer 
pH4: Methanol, (65:35) 
1.1 0.83 0.7 7.4 
10 mM ammonium acetate buffer 
pH4.5: Methanol, (65:35) 
0.9 0.7 0.5 5.8 
10 mM ammonium acetate buffer 
pH4: Methanol, (60:40) 
1.8 1.3 1.2 13 
10 mM ammonium acetate buffer 
pH4.5: Methanol, (60:40) 
1.4 1.0 0.8 11 
 
Varian HPLC: Chromatogram showing compound peaks in water, pH 3 adjusted with acetic 
acid: acetonitrile, 50:50 (v/v). Peaks 1: 2OH and CBX, 2: 1OH, 3: IBU 
1 
2 
3 
Agilent HPLC: Chromatogram showing compound peaks in water, pH 3 adjusted with 
acetic acid: acetonitrile, 60:40 (v/v). Peaks 1: 2OH, CBX, 2: 1OH, 3: IBU 
1 
2 3 
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Response function results for the 22 factorial design 
Mobile Phase CRS CRF CEF Rsum Rcp RP Runtime 
(min) 
1 -3705 28 42 42 1.5 2 23 
2 14 39 12 40 2.5 4 19 
3 100 6.3 113 50 1.4 2 38 
4 24 23 19 50 3.1 4 33 
 
b. USP 
Vm = 0.0005 x (4.6)2x250 = 2.645 mL 
Gradient retention factor k*= (0.87 x 15 X 2)/ (2.645 x 0.95 x 4) = 2.6   
∆tr/tG = 4.539/15 = 0.30                     
Isocratic %B ≈ 6.3 (travg – tD) - 2 = 6.3 [10.010 – 2.645/2] = 52.7%    
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chromatogram of compound separation in synthetic wastewater with optimized HPLC gradient 
conditions: water (solvent A), acetonitrile (solvent B), both acidified with 0.01% formic acid (v/v) 
Peaks 1: BA, 2: 2OH, 3: CBX, 4: 1OH, 5: 
IBU 
1 
5 
4 
3
3 
2 
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Annex 4. HPLC Validation Graphs and Calculations 
a. Linearity Calibration Curve 
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 HPLC calibration curve for 1OH in water 
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HPLC calibration curve for 1OH in synthetic wastewater 
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b. Residual Plots 
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c. LOD Conditions and Calibration Curves 
 
 HPLC LOD acceptance conditions for accuracy of calculations 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Compound 10 x LOD > 15 µg/L, cmin LOD < 15 µg/L, cmin 
1OH 32 3.2 
2OH 38 3.8 
CBX 43 4.3 
IBU 75 7.5 
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R² = 0.99
0
0.02
0.04
0.06
0.08
0 0.5 1 1.5 2 2.5
P
2
O
H
/P
B
A
C2OH/CBA
y = 0.0308x + 0.0007
R² = 0.9942
0
0.01
0.02
0.03
0.04
0.05
0.06
0.07
0 0.5 1 1.5 2 2.5
P
1
O
H
/P
B
A
C1OH/CBA
y = 0.03x + 0.0022
R² = 0.9894
0
0.01
0.02
0.03
0.04
0.05
0.06
0.07
0 0.5 1 1.5 2 2.5
P
C
B
X
/P
B
A
CBCX/CBA
y = 0.0182x - 0.0028
R² = 0.9681
0
0.005
0.01
0.015
0.02
0.025
0.03
0.035
0 0.5 1 1.5 2 2.5
P
IB
U
/P
B
A
CIBU/CBA
HPLC LOD Calibration curves for the four compounds in water 
2OH CBX 
1OH IBU 
129 
Annex 5. CE Electropherograms 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Electropherogram of sample T4 (120 min) taken from aerobic reactor: no compounds detected 
BA 
Electropherogram of separation observed in 15 mM borate, 40 mM SDS, 20% acetonitrile 
1 2 3 4 
Electropherogram of compound separation in synthetic wastewater in 
optimized MEKC conditions 
15 mM borate, 40 mM SDS, 10%THF; Peaks 1: 2OH, 2: 1OH, 
3: IBU,4: BA, 5: CBX 
2 1 3 5 4 
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Annex 6. CE Graphs and Validation Calculations  
a. Linearity Calibration Curves 
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b. Residual Plots 
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c. LOD Conditions and Calibration Curves 
 
 CE LOD acceptance conditions for accuracy of calculations 
 
 
 
 
 
Compound 10 x LOD > 15 µg/L, cmin LOD < 15 µg/L, cmin 
1OH 33 3.2 
2OH 39 3.3 
CBX 51 5.1 
IBU 151 15 
y = 0.0551x + 5E-05
R² = 0.9905
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